Validation pour Ingenuity256

vers la météo de la validation par utilisateur

Ingenuity256

precedent - 0 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 - suivant

Phrase 3 - PMID ?

In liver from male SP missing a adrenal gland , intravenous administration of NODE ( with a dosage of 50 mg/kg ) is involved in expression of SP NODE mRNA 72 hours after initial treatment .

name="reponse" value="NA"> Non annotée
name="reponse" value="JSP"> Je ne sais pas
name="reponse" value="INS"> Je n'ai pas trouvé d'analyse satisfaisante

Commentaires :

<?php echo $Com ; ?>

name="reponse" value="A0">Analyse 0

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+-------------------------COMP:V_PASS-N(after)------------------------+      
      |                       +-------------------------------------------SUBJ:V_PASS-N------------------------------------------+            +-------COMP:N-N(of)-------+                             |      
      +-COMP:N-N(from)-+      +-----OBJ:V-N----+----------APPOS---------+                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-N (__SP__,male)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
SUBJ:V_PASS-N (involve,miss)
COMP:V_PASS-N(in) (involve,expression)
COMP:V_PASS-N(after) (involve,treatment)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

name="reponse" value="A1">Analyse 1

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+-------------------------COMP:V_PASS-N(after)------------------------+      
      |                       +-------------------------------------------SUBJ:V_PASS-N------------------------------------------+            +-------COMP:N-N(of)-------+                             |      
      +-COMP:N-N(from)-+      +-----OBJ:V-N----+----------APPOS---------+                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-ADJ (__SP__,male)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
SUBJ:V_PASS-N (involve,miss)
COMP:V_PASS-N(in) (involve,expression)
COMP:V_PASS-N(after) (involve,treatment)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

name="reponse" value="A2">Analyse 2

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+-------------------------COMP:V_PASS-N(after)------------------------+      
      |                       +-------------------------------------------SUBJ:V_PASS-N------------------------------------------+            +-------COMP:N-N(of)-------+                             |      
      +-COMP:N-N(from)-+      +-----OBJ:V-N----+----------APPOS---------+                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-N (__SP__,male)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
SUBJ:V_PASS-N (involve,miss)
COMP:V_PASS-N(in) (involve,expression)
COMP:V_PASS-N(after) (involve,treatment)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

name="reponse" value="A3">Analyse 3

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+-------------------------COMP:V_PASS-N(after)------------------------+      
      |                       +-------------------------------------------SUBJ:V_PASS-N------------------------------------------+            +-------COMP:N-N(of)-------+                             |      
      +-COMP:N-N(from)-+      +-----OBJ:V-N----+----------APPOS---------+                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-ADJ (__SP__,male)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
SUBJ:V_PASS-N (involve,miss)
COMP:V_PASS-N(in) (involve,expression)
COMP:V_PASS-N(after) (involve,treatment)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

name="reponse" value="A4">Analyse 4

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+-------------------------COMP:V_PASS-N(after)------------------------+      
      |                                        +----------------------------------SUBJ:V_PASS-N----------------------------------+            +-------COMP:N-N(of)-------+                             |      
      +-COMP:N-N(from)-+                       +----------APPOS---------+                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+SUBJ:V+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-N (__SP__,male)
SUBJ:V-N (miss,__SP__)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
SUBJ:V_PASS-N (involve,gland)
COMP:V_PASS-N(in) (involve,expression)
COMP:V_PASS-N(after) (involve,treatment)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

name="reponse" value="A5">Analyse 5

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+-------------------------COMP:V_PASS-N(after)------------------------+      
      |                                        +----------------------------------SUBJ:V_PASS-N----------------------------------+            +-------COMP:N-N(of)-------+                             |      
      +-COMP:N-N(from)-+                       +----------APPOS---------+                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+SUBJ:V+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-ADJ (__SP__,male)
SUBJ:V-N (miss,__SP__)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
SUBJ:V_PASS-N (involve,gland)
COMP:V_PASS-N(in) (involve,expression)
COMP:V_PASS-N(after) (involve,treatment)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

name="reponse" value="A6">Analyse 6

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+-------------------------COMP:V_PASS-N(after)------------------------+      
      |                                        +----------------------------------SUBJ:V_PASS-N----------------------------------+            +-------COMP:N-N(of)-------+                             |      
      +-COMP:N-N(from)-+                       +----------APPOS---------+                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+SUBJ:V+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-N (__SP__,male)
SUBJ:V-N (miss,__SP__)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
SUBJ:V_PASS-N (involve,gland)
COMP:V_PASS-N(in) (involve,expression)
COMP:V_PASS-N(after) (involve,treatment)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

name="reponse" value="A7">Analyse 7

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+-------------------------COMP:V_PASS-N(after)------------------------+      
      |                                        +----------------------------------SUBJ:V_PASS-N----------------------------------+            +-------COMP:N-N(of)-------+                             |      
      +-COMP:N-N(from)-+                       +----------APPOS---------+                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+SUBJ:V+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-ADJ (__SP__,male)
SUBJ:V-N (miss,__SP__)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
SUBJ:V_PASS-N (involve,gland)
COMP:V_PASS-N(in) (involve,expression)
COMP:V_PASS-N(after) (involve,treatment)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

name="reponse" value="A8">Analyse 8

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+-------------------------COMP:V_PASS-N(after)------------------------+      
      |                       +-------------------------------------------SUBJ:V_PASS-N------------------------------------------+            +-------COMP:N-N(of)-------+                             |      
      +-COMP:N-N(from)-+      +-----OBJ:V-N----+----------APPOS---------+                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-N (__SP__,male)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
SUBJ:V_PASS-N (involve,miss)
COMP:V_PASS-N(in) (involve,expression)
COMP:V_PASS-N(after) (involve,treatment)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

name="reponse" value="A9">Analyse 9

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+-------------------------COMP:V_PASS-N(after)------------------------+      
      |                       +-------------------------------------------SUBJ:V_PASS-N------------------------------------------+            +-------COMP:N-N(of)-------+                             |      
      +-COMP:N-N(from)-+      +-----OBJ:V-N----+----------APPOS---------+                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-ADJ (__SP__,male)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
SUBJ:V_PASS-N (involve,miss)
COMP:V_PASS-N(in) (involve,expression)
COMP:V_PASS-N(after) (involve,treatment)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

name="reponse" value="A10">Analyse 10

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+                                                                            
      |                +-------------------------------------------COMP:V_PASS-N(from)-------------------------------------------+-------------------------COMP:V_PASS-N(after)------------------------+      
      |                |      +-------------------------------------------SUBJ:V_PASS-N------------------------------------------+            +-------COMP:N-N(of)-------+                             |      
      |                |      +-----OBJ:V-N----+----------APPOS---------+                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
MOD_ATT:N-N (__SP__,male)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
COMP:V_PASS-N(from) (involve,__SP__)
SUBJ:V_PASS-N (involve,miss)
COMP:V_PASS-N(in) (involve,expression)
COMP:V_PASS-N(after) (involve,treatment)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

name="reponse" value="A11">Analyse 11

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+                                                                            
      |                +-------------------------------------------COMP:V_PASS-N(from)-------------------------------------------+-------------------------COMP:V_PASS-N(after)------------------------+      
      |                |      +-------------------------------------------SUBJ:V_PASS-N------------------------------------------+            +-------COMP:N-N(of)-------+                             |      
      |                |      +-----OBJ:V-N----+----------APPOS---------+                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
MOD_ATT:N-ADJ (__SP__,male)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
COMP:V_PASS-N(from) (involve,__SP__)
SUBJ:V_PASS-N (involve,miss)
COMP:V_PASS-N(in) (involve,expression)
COMP:V_PASS-N(after) (involve,treatment)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

name="reponse" value="A12">Analyse 12

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+-------------------------COMP:V_PASS-N(after)------------------------+      
      |                       +-------------------------------------------SUBJ:V_PASS-N------------------------------------------+            +-------COMP:N-N(of)-------+                             |      
      +-COMP:N-N(from)-+      +-----OBJ:V-N----+----------APPOS---------+                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-N (__SP__,male)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
SUBJ:V_PASS-N (involve,miss)
COMP:V_PASS-N(in) (involve,expression)
COMP:V_PASS-N(after) (involve,treatment)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

name="reponse" value="A13">Analyse 13

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+-------------------------COMP:V_PASS-N(after)------------------------+      
      |                       +-------------------------------------------SUBJ:V_PASS-N------------------------------------------+            +-------COMP:N-N(of)-------+                             |      
      +-COMP:N-N(from)-+      +-----OBJ:V-N----+----------APPOS---------+                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-ADJ (__SP__,male)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
SUBJ:V_PASS-N (involve,miss)
COMP:V_PASS-N(in) (involve,expression)
COMP:V_PASS-N(after) (involve,treatment)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

name="reponse" value="A14">Analyse 14

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+                                                                            
      |                +-------------------------------------------COMP:V_PASS-N(from)-------------------------------------------+-------------------------COMP:V_PASS-N(after)------------------------+      
      |                |      +-------------------------------------------SUBJ:V_PASS-N------------------------------------------+            +-------COMP:N-N(of)-------+                             |      
      |                |      +-----OBJ:V-N----+----------APPOS---------+                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
MOD_ATT:N-N (__SP__,male)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
COMP:V_PASS-N(from) (involve,__SP__)
SUBJ:V_PASS-N (involve,miss)
COMP:V_PASS-N(in) (involve,expression)
COMP:V_PASS-N(after) (involve,treatment)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

name="reponse" value="A15">Analyse 15

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+                                                                            
      |                +-------------------------------------------COMP:V_PASS-N(from)-------------------------------------------+-------------------------COMP:V_PASS-N(after)------------------------+      
      |                |      +-------------------------------------------SUBJ:V_PASS-N------------------------------------------+            +-------COMP:N-N(of)-------+                             |      
      |                |      +-----OBJ:V-N----+----------APPOS---------+                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
MOD_ATT:N-ADJ (__SP__,male)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
COMP:V_PASS-N(from) (involve,__SP__)
SUBJ:V_PASS-N (involve,miss)
COMP:V_PASS-N(in) (involve,expression)
COMP:V_PASS-N(after) (involve,treatment)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

name="reponse" value="A16">Analyse 16

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+-------------------------COMP:V_PASS-N(after)------------------------+      
      |                                                                 +----------------------SUBJ:V_PASS-N---------------------+            +-------COMP:N-N(of)-------+                             |      
      +-COMP:N-N(from)-+      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-N (__SP__,male)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
SUBJ:V_PASS-N (involve,administration)
COMP:V_PASS-N(in) (involve,expression)
COMP:V_PASS-N(after) (involve,treatment)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

name="reponse" value="A17">Analyse 17

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+-------------------------COMP:V_PASS-N(after)------------------------+      
      |                                                                 +----------------------SUBJ:V_PASS-N---------------------+            +-------COMP:N-N(of)-------+                             |      
      +-COMP:N-N(from)-+      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-ADJ (__SP__,male)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
SUBJ:V_PASS-N (involve,administration)
COMP:V_PASS-N(in) (involve,expression)
COMP:V_PASS-N(after) (involve,treatment)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

name="reponse" value="A18">Analyse 18

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+-------------------------COMP:V_PASS-N(after)------------------------+      
      |                                                                 +----------------------SUBJ:V_PASS-N---------------------+            +-------COMP:N-N(of)-------+                             |      
      +-COMP:N-N(from)-+      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+SUBJ:V+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-N (__SP__,male)
SUBJ:V-N (miss,__SP__)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
SUBJ:V_PASS-N (involve,administration)
COMP:V_PASS-N(in) (involve,expression)
COMP:V_PASS-N(after) (involve,treatment)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

name="reponse" value="A19">Analyse 19

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+-------------------------COMP:V_PASS-N(after)------------------------+      
      |                                                                 +----------------------SUBJ:V_PASS-N---------------------+            +-------COMP:N-N(of)-------+                             |      
      +-COMP:N-N(from)-+      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+SUBJ:V+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-ADJ (__SP__,male)
SUBJ:V-N (miss,__SP__)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
SUBJ:V_PASS-N (involve,administration)
COMP:V_PASS-N(in) (involve,expression)
COMP:V_PASS-N(after) (involve,treatment)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

name="reponse" value="A20">Analyse 20

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+-------------------------COMP:V_PASS-N(after)------------------------+      
      |                                                                 +----------------------SUBJ:V_PASS-N---------------------+            +-------COMP:N-N(of)-------+                             |      
      +-COMP:N-N(from)-+      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-N (__SP__,male)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
SUBJ:V_PASS-N (involve,administration)
COMP:V_PASS-N(in) (involve,expression)
COMP:V_PASS-N(after) (involve,treatment)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

name="reponse" value="A21">Analyse 21

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+-------------------------COMP:V_PASS-N(after)------------------------+      
      |                                                                 +----------------------SUBJ:V_PASS-N---------------------+            +-------COMP:N-N(of)-------+                             |      
      +-COMP:N-N(from)-+      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-ADJ (__SP__,male)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
SUBJ:V_PASS-N (involve,administration)
COMP:V_PASS-N(in) (involve,expression)
COMP:V_PASS-N(after) (involve,treatment)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

name="reponse" value="A22">Analyse 22

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+-------------------------COMP:V_PASS-N(after)------------------------+      
      |                                                                 +----------------------SUBJ:V_PASS-N---------------------+            +-------COMP:N-N(of)-------+                             |      
      +-COMP:N-N(from)-+      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+SUBJ:V+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-N (__SP__,male)
SUBJ:V-N (miss,__SP__)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
SUBJ:V_PASS-N (involve,administration)
COMP:V_PASS-N(in) (involve,expression)
COMP:V_PASS-N(after) (involve,treatment)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

name="reponse" value="A23">Analyse 23

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+-------------------------COMP:V_PASS-N(after)------------------------+      
      |                                                                 +----------------------SUBJ:V_PASS-N---------------------+            +-------COMP:N-N(of)-------+                             |      
      +-COMP:N-N(from)-+      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+SUBJ:V+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-ADJ (__SP__,male)
SUBJ:V-N (miss,__SP__)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
SUBJ:V_PASS-N (involve,administration)
COMP:V_PASS-N(in) (involve,expression)
COMP:V_PASS-N(after) (involve,treatment)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

name="reponse" value="A24">Analyse 24

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+-------------------------COMP:V_PASS-N(after)------------------------+      
      |                                        +----------------------------------SUBJ:V_PASS-N----------------------------------+            +-------COMP:N-N(of)-------+                             |      
      +-COMP:N-N(from)-+                       +----------APPOS---------+                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+SUBJ:V+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-N (__SP__,male)
SUBJ:V-N (miss,__SP__)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
SUBJ:V_PASS-N (involve,gland)
COMP:V_PASS-N(in) (involve,expression)
COMP:V_PASS-N(after) (involve,treatment)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

name="reponse" value="A25">Analyse 25

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+-------------------------COMP:V_PASS-N(after)------------------------+      
      |                                        +----------------------------------SUBJ:V_PASS-N----------------------------------+            +-------COMP:N-N(of)-------+                             |      
      +-COMP:N-N(from)-+                       +----------APPOS---------+                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+SUBJ:V+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-ADJ (__SP__,male)
SUBJ:V-N (miss,__SP__)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
SUBJ:V_PASS-N (involve,gland)
COMP:V_PASS-N(in) (involve,expression)
COMP:V_PASS-N(after) (involve,treatment)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

name="reponse" value="A26">Analyse 26

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+-------------------------COMP:V_PASS-N(after)------------------------+      
      |                                        +----------------------------------SUBJ:V_PASS-N----------------------------------+            +-------COMP:N-N(of)-------+                             |      
      +-COMP:N-N(from)-+                       +----------APPOS---------+                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+SUBJ:V+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-N (__SP__,male)
SUBJ:V-N (miss,__SP__)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
SUBJ:V_PASS-N (involve,gland)
COMP:V_PASS-N(in) (involve,expression)
COMP:V_PASS-N(after) (involve,treatment)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

name="reponse" value="A27">Analyse 27

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+-------------------------COMP:V_PASS-N(after)------------------------+      
      |                                        +----------------------------------SUBJ:V_PASS-N----------------------------------+            +-------COMP:N-N(of)-------+                             |      
      +-COMP:N-N(from)-+                       +----------APPOS---------+                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+SUBJ:V+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-ADJ (__SP__,male)
SUBJ:V-N (miss,__SP__)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
SUBJ:V_PASS-N (involve,gland)
COMP:V_PASS-N(in) (involve,expression)
COMP:V_PASS-N(after) (involve,treatment)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

name="reponse" value="A28">Analyse 28

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+                                                                            
      |                +-------------------------------------------COMP:V_PASS-N(from)-------------------------------------------+-------------------------COMP:V_PASS-N(after)------------------------+      
      |                |      +-------------------------------------------SUBJ:V_PASS-N------------------------------------------+            +-------COMP:N-N(of)-------+                             |      
      |                |      +-----OBJ:V-N----+----------APPOS---------+                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
MOD_ATT:N-N (__SP__,male)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
COMP:V_PASS-N(from) (involve,__SP__)
SUBJ:V_PASS-N (involve,miss)
COMP:V_PASS-N(in) (involve,expression)
COMP:V_PASS-N(after) (involve,treatment)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

name="reponse" value="A29">Analyse 29

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+                                                                            
      |                +-------------------------------------------COMP:V_PASS-N(from)-------------------------------------------+-------------------------COMP:V_PASS-N(after)------------------------+      
      |                |      +-------------------------------------------SUBJ:V_PASS-N------------------------------------------+            +-------COMP:N-N(of)-------+                             |      
      |                |      +-----OBJ:V-N----+----------APPOS---------+                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
MOD_ATT:N-ADJ (__SP__,male)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
COMP:V_PASS-N(from) (involve,__SP__)
SUBJ:V_PASS-N (involve,miss)
COMP:V_PASS-N(in) (involve,expression)
COMP:V_PASS-N(after) (involve,treatment)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

name="reponse" value="A30">Analyse 30

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+                                                                            
      |                +-------------------------------------------COMP:V_PASS-N(from)-------------------------------------------+-------------------------COMP:V_PASS-N(after)------------------------+      
      |                |      +-------------------------------------------SUBJ:V_PASS-N------------------------------------------+            +-------COMP:N-N(of)-------+                             |      
      |                |      +-----OBJ:V-N----+----------APPOS---------+                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
MOD_ATT:N-N (__SP__,male)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
COMP:V_PASS-N(from) (involve,__SP__)
SUBJ:V_PASS-N (involve,miss)
COMP:V_PASS-N(in) (involve,expression)
COMP:V_PASS-N(after) (involve,treatment)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

name="reponse" value="A31">Analyse 31

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+                                                                            
      |                +-------------------------------------------COMP:V_PASS-N(from)-------------------------------------------+-------------------------COMP:V_PASS-N(after)------------------------+      
      |                |      +-------------------------------------------SUBJ:V_PASS-N------------------------------------------+            +-------COMP:N-N(of)-------+                             |      
      |                |      +-----OBJ:V-N----+----------APPOS---------+                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
MOD_ATT:N-ADJ (__SP__,male)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
COMP:V_PASS-N(from) (involve,__SP__)
SUBJ:V_PASS-N (involve,miss)
COMP:V_PASS-N(in) (involve,expression)
COMP:V_PASS-N(after) (involve,treatment)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

name="reponse" value="A32">Analyse 32

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+-------------------------COMP:V_PASS-N(after)------------------------+      
      +--------SUBJ:V-N-------+                +----------------------------------SUBJ:V_PASS-N----------------------------------+            +-------COMP:N-N(of)-------+                             |      
      +-COMP:N-N(from)-+      |                +----------APPOS---------+                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-N (__SP__,male)
SUBJ:V-N (miss,liver)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
SUBJ:V_PASS-N (involve,gland)
COMP:V_PASS-N(in) (involve,expression)
COMP:V_PASS-N(after) (involve,treatment)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

name="reponse" value="A33">Analyse 33

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+-------------------------COMP:V_PASS-N(after)------------------------+      
      +--------SUBJ:V-N-------+                +----------------------------------SUBJ:V_PASS-N----------------------------------+            +-------COMP:N-N(of)-------+                             |      
      +-COMP:N-N(from)-+      |                +----------APPOS---------+                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-ADJ (__SP__,male)
SUBJ:V-N (miss,liver)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
SUBJ:V_PASS-N (involve,gland)
COMP:V_PASS-N(in) (involve,expression)
COMP:V_PASS-N(after) (involve,treatment)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

name="reponse" value="A34">Analyse 34

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+-------------------------COMP:V_PASS-N(after)------------------------+      
      +--------SUBJ:V-N-------+                +----------------------------------SUBJ:V_PASS-N----------------------------------+            +-------COMP:N-N(of)-------+                             |      
      +-COMP:N-N(from)-+      |                +----------APPOS---------+                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-N (__SP__,male)
SUBJ:V-N (miss,liver)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
SUBJ:V_PASS-N (involve,gland)
COMP:V_PASS-N(in) (involve,expression)
COMP:V_PASS-N(after) (involve,treatment)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

name="reponse" value="A35">Analyse 35

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+-------------------------COMP:V_PASS-N(after)------------------------+      
      +--------SUBJ:V-N-------+                +----------------------------------SUBJ:V_PASS-N----------------------------------+            +-------COMP:N-N(of)-------+                             |      
      +-COMP:N-N(from)-+      |                +----------APPOS---------+                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-ADJ (__SP__,male)
SUBJ:V-N (miss,liver)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
SUBJ:V_PASS-N (involve,gland)
COMP:V_PASS-N(in) (involve,expression)
COMP:V_PASS-N(after) (involve,treatment)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

name="reponse" value="A36">Analyse 36

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+-------------------------COMP:V_PASS-N(after)------------------------+      
      |                                                                 +----------------------SUBJ:V_PASS-N---------------------+            +-------COMP:N-N(of)-------+                             |      
      +-COMP:N-N(from)-+      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-N (__SP__,male)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
SUBJ:V_PASS-N (involve,administration)
COMP:V_PASS-N(in) (involve,expression)
COMP:V_PASS-N(after) (involve,treatment)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

name="reponse" value="A37">Analyse 37

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+-------------------------COMP:V_PASS-N(after)------------------------+      
      |                                                                 +----------------------SUBJ:V_PASS-N---------------------+            +-------COMP:N-N(of)-------+                             |      
      +-COMP:N-N(from)-+      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-ADJ (__SP__,male)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
SUBJ:V_PASS-N (involve,administration)
COMP:V_PASS-N(in) (involve,expression)
COMP:V_PASS-N(after) (involve,treatment)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

name="reponse" value="A38">Analyse 38

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+-------------------------COMP:V_PASS-N(after)------------------------+      
      |                                                                 +----------------------SUBJ:V_PASS-N---------------------+            +-------COMP:N-N(of)-------+                             |      
      +-COMP:N-N(from)-+      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+SUBJ:V+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-N (__SP__,male)
SUBJ:V-N (miss,__SP__)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
SUBJ:V_PASS-N (involve,administration)
COMP:V_PASS-N(in) (involve,expression)
COMP:V_PASS-N(after) (involve,treatment)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

name="reponse" value="A39">Analyse 39

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+-------------------------COMP:V_PASS-N(after)------------------------+      
      |                                                                 +----------------------SUBJ:V_PASS-N---------------------+            +-------COMP:N-N(of)-------+                             |      
      +-COMP:N-N(from)-+      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+SUBJ:V+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-ADJ (__SP__,male)
SUBJ:V-N (miss,__SP__)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
SUBJ:V_PASS-N (involve,administration)
COMP:V_PASS-N(in) (involve,expression)
COMP:V_PASS-N(after) (involve,treatment)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

name="reponse" value="A40">Analyse 40

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+-------------------------COMP:V_PASS-N(after)------------------------+      
      |                                                                 +----------------------SUBJ:V_PASS-N---------------------+            +-------COMP:N-N(of)-------+                             |      
      +-COMP:N-N(from)-+      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-N (__SP__,male)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
SUBJ:V_PASS-N (involve,administration)
COMP:V_PASS-N(in) (involve,expression)
COMP:V_PASS-N(after) (involve,treatment)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

name="reponse" value="A41">Analyse 41

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+-------------------------COMP:V_PASS-N(after)------------------------+      
      |                                                                 +----------------------SUBJ:V_PASS-N---------------------+            +-------COMP:N-N(of)-------+                             |      
      +-COMP:N-N(from)-+      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-ADJ (__SP__,male)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
SUBJ:V_PASS-N (involve,administration)
COMP:V_PASS-N(in) (involve,expression)
COMP:V_PASS-N(after) (involve,treatment)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

name="reponse" value="A42">Analyse 42

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+-------------------------COMP:V_PASS-N(after)------------------------+      
      |                                                                 +----------------------SUBJ:V_PASS-N---------------------+            +-------COMP:N-N(of)-------+                             |      
      +-COMP:N-N(from)-+      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+SUBJ:V+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-N (__SP__,male)
SUBJ:V-N (miss,__SP__)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
SUBJ:V_PASS-N (involve,administration)
COMP:V_PASS-N(in) (involve,expression)
COMP:V_PASS-N(after) (involve,treatment)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

name="reponse" value="A43">Analyse 43

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+-------------------------COMP:V_PASS-N(after)------------------------+      
      |                                                                 +----------------------SUBJ:V_PASS-N---------------------+            +-------COMP:N-N(of)-------+                             |      
      +-COMP:N-N(from)-+      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+SUBJ:V+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-ADJ (__SP__,male)
SUBJ:V-N (miss,__SP__)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
SUBJ:V_PASS-N (involve,administration)
COMP:V_PASS-N(in) (involve,expression)
COMP:V_PASS-N(after) (involve,treatment)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

name="reponse" value="A44">Analyse 44

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+-------------------------COMP:V_PASS-N(after)------------------------+      
      +--------SUBJ:V-N-------+                                         +----------------------SUBJ:V_PASS-N---------------------+            +-------COMP:N-N(of)-------+                             |      
      +-COMP:N-N(from)-+      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-N (__SP__,male)
SUBJ:V-N (miss,liver)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
SUBJ:V_PASS-N (involve,administration)
COMP:V_PASS-N(in) (involve,expression)
COMP:V_PASS-N(after) (involve,treatment)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

name="reponse" value="A45">Analyse 45

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+-------------------------COMP:V_PASS-N(after)------------------------+      
      +--------SUBJ:V-N-------+                                         +----------------------SUBJ:V_PASS-N---------------------+            +-------COMP:N-N(of)-------+                             |      
      +-COMP:N-N(from)-+      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-ADJ (__SP__,male)
SUBJ:V-N (miss,liver)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
SUBJ:V_PASS-N (involve,administration)
COMP:V_PASS-N(in) (involve,expression)
COMP:V_PASS-N(after) (involve,treatment)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

name="reponse" value="A46">Analyse 46

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+-------------------------COMP:V_PASS-N(after)------------------------+      
      +--------SUBJ:V-N-------+                                         +----------------------SUBJ:V_PASS-N---------------------+            +-------COMP:N-N(of)-------+                             |      
      +-COMP:N-N(from)-+      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-N (__SP__,male)
SUBJ:V-N (miss,liver)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
SUBJ:V_PASS-N (involve,administration)
COMP:V_PASS-N(in) (involve,expression)
COMP:V_PASS-N(after) (involve,treatment)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

name="reponse" value="A47">Analyse 47

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+-------------------------COMP:V_PASS-N(after)------------------------+      
      +--------SUBJ:V-N-------+                                         +----------------------SUBJ:V_PASS-N---------------------+            +-------COMP:N-N(of)-------+                             |      
      +-COMP:N-N(from)-+      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-ADJ (__SP__,male)
SUBJ:V-N (miss,liver)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
SUBJ:V_PASS-N (involve,administration)
COMP:V_PASS-N(in) (involve,expression)
COMP:V_PASS-N(after) (involve,treatment)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

name="reponse" value="A48">Analyse 48

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+-------------------------COMP:V_PASS-N(after)------------------------+      
      +--------SUBJ:V-N-------+                +----------------------------------SUBJ:V_PASS-N----------------------------------+            +-------COMP:N-N(of)-------+                             |      
      +-COMP:N-N(from)-+      |                +----------APPOS---------+                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-N (__SP__,male)
SUBJ:V-N (miss,liver)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
SUBJ:V_PASS-N (involve,gland)
COMP:V_PASS-N(in) (involve,expression)
COMP:V_PASS-N(after) (involve,treatment)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

name="reponse" value="A49">Analyse 49

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+-------------------------COMP:V_PASS-N(after)------------------------+      
      +--------SUBJ:V-N-------+                +----------------------------------SUBJ:V_PASS-N----------------------------------+            +-------COMP:N-N(of)-------+                             |      
      +-COMP:N-N(from)-+      |                +----------APPOS---------+                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-ADJ (__SP__,male)
SUBJ:V-N (miss,liver)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
SUBJ:V_PASS-N (involve,gland)
COMP:V_PASS-N(in) (involve,expression)
COMP:V_PASS-N(after) (involve,treatment)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

name="reponse" value="A50">Analyse 50

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+                                                                            
      |                +-------------------------------------------COMP:V_PASS-N(from)-------------------------------------------+-------------------------COMP:V_PASS-N(after)------------------------+      
      |                |                       +----------------------------------SUBJ:V_PASS-N----------------------------------+            +-------COMP:N-N(of)-------+                             |      
      |                |                       +----------APPOS---------+                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+SUBJ:V+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
MOD_ATT:N-N (__SP__,male)
SUBJ:V-N (miss,__SP__)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
COMP:V_PASS-N(from) (involve,__SP__)
SUBJ:V_PASS-N (involve,gland)
COMP:V_PASS-N(in) (involve,expression)
COMP:V_PASS-N(after) (involve,treatment)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

name="reponse" value="A51">Analyse 51

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+                                                                            
      |                +-------------------------------------------COMP:V_PASS-N(from)-------------------------------------------+-------------------------COMP:V_PASS-N(after)------------------------+      
      |                |                       +----------------------------------SUBJ:V_PASS-N----------------------------------+            +-------COMP:N-N(of)-------+                             |      
      |                |                       +----------APPOS---------+                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+SUBJ:V+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
MOD_ATT:N-ADJ (__SP__,male)
SUBJ:V-N (miss,__SP__)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
COMP:V_PASS-N(from) (involve,__SP__)
SUBJ:V_PASS-N (involve,gland)
COMP:V_PASS-N(in) (involve,expression)
COMP:V_PASS-N(after) (involve,treatment)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

name="reponse" value="A52">Analyse 52

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+-------------------------COMP:V_PASS-N(after)------------------------+      
      +--------SUBJ:V-N-------+                +----------------------------------SUBJ:V_PASS-N----------------------------------+            +-------COMP:N-N(of)-------+                             |      
      +-COMP:N-N(from)-+      |                +----------APPOS---------+                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-N (__SP__,male)
SUBJ:V-N (miss,liver)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
SUBJ:V_PASS-N (involve,gland)
COMP:V_PASS-N(in) (involve,expression)
COMP:V_PASS-N(after) (involve,treatment)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

name="reponse" value="A53">Analyse 53

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+-------------------------COMP:V_PASS-N(after)------------------------+      
      +--------SUBJ:V-N-------+                +----------------------------------SUBJ:V_PASS-N----------------------------------+            +-------COMP:N-N(of)-------+                             |      
      +-COMP:N-N(from)-+      |                +----------APPOS---------+                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-ADJ (__SP__,male)
SUBJ:V-N (miss,liver)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
SUBJ:V_PASS-N (involve,gland)
COMP:V_PASS-N(in) (involve,expression)
COMP:V_PASS-N(after) (involve,treatment)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

name="reponse" value="A54">Analyse 54

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+                                                                            
      |                +-------------------------------------------COMP:V_PASS-N(from)-------------------------------------------+-------------------------COMP:V_PASS-N(after)------------------------+      
      |                |                       +----------------------------------SUBJ:V_PASS-N----------------------------------+            +-------COMP:N-N(of)-------+                             |      
      |                |                       +----------APPOS---------+                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+SUBJ:V+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
MOD_ATT:N-N (__SP__,male)
SUBJ:V-N (miss,__SP__)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
COMP:V_PASS-N(from) (involve,__SP__)
SUBJ:V_PASS-N (involve,gland)
COMP:V_PASS-N(in) (involve,expression)
COMP:V_PASS-N(after) (involve,treatment)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

name="reponse" value="A55">Analyse 55

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+                                                                            
      |                +-------------------------------------------COMP:V_PASS-N(from)-------------------------------------------+-------------------------COMP:V_PASS-N(after)------------------------+      
      |                |                       +----------------------------------SUBJ:V_PASS-N----------------------------------+            +-------COMP:N-N(of)-------+                             |      
      |                |                       +----------APPOS---------+                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+SUBJ:V+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
MOD_ATT:N-ADJ (__SP__,male)
SUBJ:V-N (miss,__SP__)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
COMP:V_PASS-N(from) (involve,__SP__)
SUBJ:V_PASS-N (involve,gland)
COMP:V_PASS-N(in) (involve,expression)
COMP:V_PASS-N(after) (involve,treatment)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

name="reponse" value="A56">Analyse 56

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+-------------------------COMP:V_PASS-N(after)------------------------+      
      +--------SUBJ:V-N-------+                                         +----------------------SUBJ:V_PASS-N---------------------+            +-------COMP:N-N(of)-------+                             |      
      +-COMP:N-N(from)-+      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-N (__SP__,male)
SUBJ:V-N (miss,liver)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
SUBJ:V_PASS-N (involve,administration)
COMP:V_PASS-N(in) (involve,expression)
COMP:V_PASS-N(after) (involve,treatment)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

name="reponse" value="A57">Analyse 57

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+-------------------------COMP:V_PASS-N(after)------------------------+      
      +--------SUBJ:V-N-------+                                         +----------------------SUBJ:V_PASS-N---------------------+            +-------COMP:N-N(of)-------+                             |      
      +-COMP:N-N(from)-+      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-ADJ (__SP__,male)
SUBJ:V-N (miss,liver)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
SUBJ:V_PASS-N (involve,administration)
COMP:V_PASS-N(in) (involve,expression)
COMP:V_PASS-N(after) (involve,treatment)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

name="reponse" value="A58">Analyse 58

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+-------------------------COMP:V_PASS-N(after)------------------------+      
      +--------SUBJ:V-N-------+                                         +----------------------SUBJ:V_PASS-N---------------------+            +-------COMP:N-N(of)-------+                             |      
      +-COMP:N-N(from)-+      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-N (__SP__,male)
SUBJ:V-N (miss,liver)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
SUBJ:V_PASS-N (involve,administration)
COMP:V_PASS-N(in) (involve,expression)
COMP:V_PASS-N(after) (involve,treatment)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

name="reponse" value="A59">Analyse 59

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+-------------------------COMP:V_PASS-N(after)------------------------+      
      +--------SUBJ:V-N-------+                                         +----------------------SUBJ:V_PASS-N---------------------+            +-------COMP:N-N(of)-------+                             |      
      +-COMP:N-N(from)-+      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-ADJ (__SP__,male)
SUBJ:V-N (miss,liver)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
SUBJ:V_PASS-N (involve,administration)
COMP:V_PASS-N(in) (involve,expression)
COMP:V_PASS-N(after) (involve,treatment)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

name="reponse" value="A60">Analyse 60

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+                                                                            
      |                +-------------------------------------------COMP:V_PASS-N(from)-------------------------------------------+-------------------------COMP:V_PASS-N(after)------------------------+      
      |                |                       +----------------------------------SUBJ:V_PASS-N----------------------------------+            +-------COMP:N-N(of)-------+                             |      
      |                |                       +----------APPOS---------+                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+SUBJ:V+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
MOD_ATT:N-N (__SP__,male)
SUBJ:V-N (miss,__SP__)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
COMP:V_PASS-N(from) (involve,__SP__)
SUBJ:V_PASS-N (involve,gland)
COMP:V_PASS-N(in) (involve,expression)
COMP:V_PASS-N(after) (involve,treatment)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

name="reponse" value="A61">Analyse 61

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+                                                                            
      |                +-------------------------------------------COMP:V_PASS-N(from)-------------------------------------------+-------------------------COMP:V_PASS-N(after)------------------------+      
      |                |                       +----------------------------------SUBJ:V_PASS-N----------------------------------+            +-------COMP:N-N(of)-------+                             |      
      |                |                       +----------APPOS---------+                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+SUBJ:V+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
MOD_ATT:N-ADJ (__SP__,male)
SUBJ:V-N (miss,__SP__)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
COMP:V_PASS-N(from) (involve,__SP__)
SUBJ:V_PASS-N (involve,gland)
COMP:V_PASS-N(in) (involve,expression)
COMP:V_PASS-N(after) (involve,treatment)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

name="reponse" value="A62">Analyse 62

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+                                                                            
      |                +-------------------------------------------COMP:V_PASS-N(from)-------------------------------------------+-------------------------COMP:V_PASS-N(after)------------------------+      
      |                |                       +----------------------------------SUBJ:V_PASS-N----------------------------------+            +-------COMP:N-N(of)-------+                             |      
      |                |                       +----------APPOS---------+                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+SUBJ:V+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
MOD_ATT:N-N (__SP__,male)
SUBJ:V-N (miss,__SP__)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
COMP:V_PASS-N(from) (involve,__SP__)
SUBJ:V_PASS-N (involve,gland)
COMP:V_PASS-N(in) (involve,expression)
COMP:V_PASS-N(after) (involve,treatment)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

name="reponse" value="A63">Analyse 63

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+                                                                            
      |                +-------------------------------------------COMP:V_PASS-N(from)-------------------------------------------+-------------------------COMP:V_PASS-N(after)------------------------+      
      |                |                       +----------------------------------SUBJ:V_PASS-N----------------------------------+            +-------COMP:N-N(of)-------+                             |      
      |                |                       +----------APPOS---------+                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+SUBJ:V+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
MOD_ATT:N-ADJ (__SP__,male)
SUBJ:V-N (miss,__SP__)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
COMP:V_PASS-N(from) (involve,__SP__)
SUBJ:V_PASS-N (involve,gland)
COMP:V_PASS-N(in) (involve,expression)
COMP:V_PASS-N(after) (involve,treatment)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

name="reponse" value="A64">Analyse 64

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+                                                                            
      |                +-------------------------------------------COMP:V_PASS-N(from)-------------------------------------------+-------------------------COMP:V_PASS-N(after)------------------------+      
      |                |                                                +----------------------SUBJ:V_PASS-N---------------------+            +-------COMP:N-N(of)-------+                             |      
      |                |      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+SUBJ:V+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
MOD_ATT:N-N (__SP__,male)
SUBJ:V-N (miss,__SP__)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
COMP:V_PASS-N(from) (involve,__SP__)
SUBJ:V_PASS-N (involve,administration)
COMP:V_PASS-N(in) (involve,expression)
COMP:V_PASS-N(after) (involve,treatment)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

name="reponse" value="A65">Analyse 65

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+                                                                            
      |                +-------------------------------------------COMP:V_PASS-N(from)-------------------------------------------+-------------------------COMP:V_PASS-N(after)------------------------+      
      |                |                                                +----------------------SUBJ:V_PASS-N---------------------+            +-------COMP:N-N(of)-------+                             |      
      |                |      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+SUBJ:V+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
MOD_ATT:N-ADJ (__SP__,male)
SUBJ:V-N (miss,__SP__)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
COMP:V_PASS-N(from) (involve,__SP__)
SUBJ:V_PASS-N (involve,administration)
COMP:V_PASS-N(in) (involve,expression)
COMP:V_PASS-N(after) (involve,treatment)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

name="reponse" value="A66">Analyse 66

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+                                                                            
      |                +-------------------------------------------COMP:V_PASS-N(from)-------------------------------------------+-------------------------COMP:V_PASS-N(after)------------------------+      
      |                |                                                +----------------------SUBJ:V_PASS-N---------------------+            +-------COMP:N-N(of)-------+                             |      
      |                |      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+SUBJ:V+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
MOD_ATT:N-N (__SP__,male)
SUBJ:V-N (miss,__SP__)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
COMP:V_PASS-N(from) (involve,__SP__)
SUBJ:V_PASS-N (involve,administration)
COMP:V_PASS-N(in) (involve,expression)
COMP:V_PASS-N(after) (involve,treatment)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

name="reponse" value="A67">Analyse 67

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+                                                                            
      |                +-------------------------------------------COMP:V_PASS-N(from)-------------------------------------------+-------------------------COMP:V_PASS-N(after)------------------------+      
      |                |                                                +----------------------SUBJ:V_PASS-N---------------------+            +-------COMP:N-N(of)-------+                             |      
      |                |      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+SUBJ:V+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
MOD_ATT:N-ADJ (__SP__,male)
SUBJ:V-N (miss,__SP__)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
COMP:V_PASS-N(from) (involve,__SP__)
SUBJ:V_PASS-N (involve,administration)
COMP:V_PASS-N(in) (involve,expression)
COMP:V_PASS-N(after) (involve,treatment)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

name="reponse" value="A68">Analyse 68

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+                                                                            
      |                +-------------------------------------------COMP:V_PASS-N(from)-------------------------------------------+-------------------------COMP:V_PASS-N(after)------------------------+      
      |                |                                                +----------------------SUBJ:V_PASS-N---------------------+            +-------COMP:N-N(of)-------+                             |      
      |                |      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+SUBJ:V+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
MOD_ATT:N-N (__SP__,male)
SUBJ:V-N (miss,__SP__)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
COMP:V_PASS-N(from) (involve,__SP__)
SUBJ:V_PASS-N (involve,administration)
COMP:V_PASS-N(in) (involve,expression)
COMP:V_PASS-N(after) (involve,treatment)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

name="reponse" value="A69">Analyse 69

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+                                                                            
      |                +-------------------------------------------COMP:V_PASS-N(from)-------------------------------------------+-------------------------COMP:V_PASS-N(after)------------------------+      
      |                |                                                +----------------------SUBJ:V_PASS-N---------------------+            +-------COMP:N-N(of)-------+                             |      
      |                |      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+SUBJ:V+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
MOD_ATT:N-ADJ (__SP__,male)
SUBJ:V-N (miss,__SP__)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
COMP:V_PASS-N(from) (involve,__SP__)
SUBJ:V_PASS-N (involve,administration)
COMP:V_PASS-N(in) (involve,expression)
COMP:V_PASS-N(after) (involve,treatment)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

name="reponse" value="A70">Analyse 70

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+                                                                            
      |                +-------------------------------------------COMP:V_PASS-N(from)-------------------------------------------+-------------------------COMP:V_PASS-N(after)------------------------+      
      |                |                                                +----------------------SUBJ:V_PASS-N---------------------+            +-------COMP:N-N(of)-------+                             |      
      |                |      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+SUBJ:V+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
MOD_ATT:N-N (__SP__,male)
SUBJ:V-N (miss,__SP__)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
COMP:V_PASS-N(from) (involve,__SP__)
SUBJ:V_PASS-N (involve,administration)
COMP:V_PASS-N(in) (involve,expression)
COMP:V_PASS-N(after) (involve,treatment)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

name="reponse" value="A71">Analyse 71

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+                                                                            
      |                +-------------------------------------------COMP:V_PASS-N(from)-------------------------------------------+-------------------------COMP:V_PASS-N(after)------------------------+      
      |                |                                                +----------------------SUBJ:V_PASS-N---------------------+            +-------COMP:N-N(of)-------+                             |      
      |                |      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+SUBJ:V+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
MOD_ATT:N-ADJ (__SP__,male)
SUBJ:V-N (miss,__SP__)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
COMP:V_PASS-N(from) (involve,__SP__)
SUBJ:V_PASS-N (involve,administration)
COMP:V_PASS-N(in) (involve,expression)
COMP:V_PASS-N(after) (involve,treatment)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

name="reponse" value="A72">Analyse 72

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+                                                                            
      |                +-------------------------------------------COMP:V_PASS-N(from)-------------------------------------------+-------------------------COMP:V_PASS-N(after)------------------------+      
      |                |                                                +----------------------SUBJ:V_PASS-N---------------------+            +-------COMP:N-N(of)-------+                             |      
      |                |      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
MOD_ATT:N-N (__SP__,male)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
COMP:V_PASS-N(from) (involve,__SP__)
SUBJ:V_PASS-N (involve,administration)
COMP:V_PASS-N(in) (involve,expression)
COMP:V_PASS-N(after) (involve,treatment)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

name="reponse" value="A73">Analyse 73

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+                                                                            
      |                +-------------------------------------------COMP:V_PASS-N(from)-------------------------------------------+-------------------------COMP:V_PASS-N(after)------------------------+      
      |                |                                                +----------------------SUBJ:V_PASS-N---------------------+            +-------COMP:N-N(of)-------+                             |      
      |                |      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
MOD_ATT:N-ADJ (__SP__,male)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
COMP:V_PASS-N(from) (involve,__SP__)
SUBJ:V_PASS-N (involve,administration)
COMP:V_PASS-N(in) (involve,expression)
COMP:V_PASS-N(after) (involve,treatment)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

name="reponse" value="A74">Analyse 74

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+                                                                            
      |                +-------------------------------------------COMP:V_PASS-N(from)-------------------------------------------+-------------------------COMP:V_PASS-N(after)------------------------+      
      |                |                                                +----------------------SUBJ:V_PASS-N---------------------+            +-------COMP:N-N(of)-------+                             |      
      |                |      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
MOD_ATT:N-N (__SP__,male)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
COMP:V_PASS-N(from) (involve,__SP__)
SUBJ:V_PASS-N (involve,administration)
COMP:V_PASS-N(in) (involve,expression)
COMP:V_PASS-N(after) (involve,treatment)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

name="reponse" value="A75">Analyse 75

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+                                                                            
      |                +-------------------------------------------COMP:V_PASS-N(from)-------------------------------------------+-------------------------COMP:V_PASS-N(after)------------------------+      
      |                |                                                +----------------------SUBJ:V_PASS-N---------------------+            +-------COMP:N-N(of)-------+                             |      
      |                |      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
MOD_ATT:N-ADJ (__SP__,male)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
COMP:V_PASS-N(from) (involve,__SP__)
SUBJ:V_PASS-N (involve,administration)
COMP:V_PASS-N(in) (involve,expression)
COMP:V_PASS-N(after) (involve,treatment)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

name="reponse" value="A76">Analyse 76

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+                                                                            
      |                +-------------------------------------------COMP:V_PASS-N(from)-------------------------------------------+-------------------------COMP:V_PASS-N(after)------------------------+      
      |                |                                                +----------------------SUBJ:V_PASS-N---------------------+            +-------COMP:N-N(of)-------+                             |      
      |                |      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
MOD_ATT:N-N (__SP__,male)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
COMP:V_PASS-N(from) (involve,__SP__)
SUBJ:V_PASS-N (involve,administration)
COMP:V_PASS-N(in) (involve,expression)
COMP:V_PASS-N(after) (involve,treatment)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

name="reponse" value="A77">Analyse 77

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+                                                                            
      |                +-------------------------------------------COMP:V_PASS-N(from)-------------------------------------------+-------------------------COMP:V_PASS-N(after)------------------------+      
      |                |                                                +----------------------SUBJ:V_PASS-N---------------------+            +-------COMP:N-N(of)-------+                             |      
      |                |      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
MOD_ATT:N-ADJ (__SP__,male)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
COMP:V_PASS-N(from) (involve,__SP__)
SUBJ:V_PASS-N (involve,administration)
COMP:V_PASS-N(in) (involve,expression)
COMP:V_PASS-N(after) (involve,treatment)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

name="reponse" value="A78">Analyse 78

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+                                                                            
      |                +-------------------------------------------COMP:V_PASS-N(from)-------------------------------------------+-------------------------COMP:V_PASS-N(after)------------------------+      
      |                |                                                +----------------------SUBJ:V_PASS-N---------------------+            +-------COMP:N-N(of)-------+                             |      
      |                |      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
MOD_ATT:N-N (__SP__,male)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
COMP:V_PASS-N(from) (involve,__SP__)
SUBJ:V_PASS-N (involve,administration)
COMP:V_PASS-N(in) (involve,expression)
COMP:V_PASS-N(after) (involve,treatment)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

name="reponse" value="A79">Analyse 79

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+                                                                            
      |                +-------------------------------------------COMP:V_PASS-N(from)-------------------------------------------+-------------------------COMP:V_PASS-N(after)------------------------+      
      |                |                                                +----------------------SUBJ:V_PASS-N---------------------+            +-------COMP:N-N(of)-------+                             |      
      |                |      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
MOD_ATT:N-ADJ (__SP__,male)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
COMP:V_PASS-N(from) (involve,__SP__)
SUBJ:V_PASS-N (involve,administration)
COMP:V_PASS-N(in) (involve,expression)
COMP:V_PASS-N(after) (involve,treatment)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

name="reponse" value="A80">Analyse 80

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+                                                                            
      |                       +-------------------------------------------SUBJ:V_PASS-N------------------------------------------+            +-------COMP:N-N(of)-------+                                    
      +-COMP:N-N(from)-+      +-----OBJ:V-N----+----------APPOS---------+                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+-------COMP:N-N(after)-------+      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-N (__SP__,male)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
SUBJ:V_PASS-N (involve,miss)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(after) (mRNA,treatment)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

name="reponse" value="A81">Analyse 81

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+                                                                            
      |                       +-------------------------------------------SUBJ:V_PASS-N------------------------------------------+            +-------COMP:N-N(of)-------+                                    
      +-COMP:N-N(from)-+      +-----OBJ:V-N----+----------APPOS---------+                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+-------COMP:N-N(after)-------+      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-ADJ (__SP__,male)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
SUBJ:V_PASS-N (involve,miss)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(after) (mRNA,treatment)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

name="reponse" value="A82">Analyse 82

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+                                                                            
      |                       +-------------------------------------------SUBJ:V_PASS-N------------------------------------------+            +-------COMP:N-N(of)-------+                                    
      +-COMP:N-N(from)-+      +-----OBJ:V-N----+----------APPOS---------+                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+-------COMP:N-N(after)-------+      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-N (__SP__,male)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
SUBJ:V_PASS-N (involve,miss)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(after) (mRNA,treatment)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

name="reponse" value="A83">Analyse 83

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+                                                                            
      |                       +-------------------------------------------SUBJ:V_PASS-N------------------------------------------+            +-------COMP:N-N(of)-------+                                    
      +-COMP:N-N(from)-+      +-----OBJ:V-N----+----------APPOS---------+                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+-------COMP:N-N(after)-------+      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-ADJ (__SP__,male)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
SUBJ:V_PASS-N (involve,miss)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(after) (mRNA,treatment)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

name="reponse" value="A84">Analyse 84

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+                                                                            
      |                                        +----------------------------------SUBJ:V_PASS-N----------------------------------+            +-------COMP:N-N(of)-------+                                    
      +-COMP:N-N(from)-+                       +----------APPOS---------+                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+-------COMP:N-N(after)-------+      
      |          +MOD_A+SUBJ:V+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-N (__SP__,male)
SUBJ:V-N (miss,__SP__)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
SUBJ:V_PASS-N (involve,gland)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(after) (mRNA,treatment)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

name="reponse" value="A85">Analyse 85

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+                                                                            
      |                                        +----------------------------------SUBJ:V_PASS-N----------------------------------+            +-------COMP:N-N(of)-------+                                    
      +-COMP:N-N(from)-+                       +----------APPOS---------+                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+-------COMP:N-N(after)-------+      
      |          +MOD_A+SUBJ:V+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-ADJ (__SP__,male)
SUBJ:V-N (miss,__SP__)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
SUBJ:V_PASS-N (involve,gland)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(after) (mRNA,treatment)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

name="reponse" value="A86">Analyse 86

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+                                                                            
      |                                        +----------------------------------SUBJ:V_PASS-N----------------------------------+            +-------COMP:N-N(of)-------+                                    
      +-COMP:N-N(from)-+                       +----------APPOS---------+                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+-------COMP:N-N(after)-------+      
      |          +MOD_A+SUBJ:V+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-N (__SP__,male)
SUBJ:V-N (miss,__SP__)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
SUBJ:V_PASS-N (involve,gland)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(after) (mRNA,treatment)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

name="reponse" value="A87">Analyse 87

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+                                                                            
      |                                        +----------------------------------SUBJ:V_PASS-N----------------------------------+            +-------COMP:N-N(of)-------+                                    
      +-COMP:N-N(from)-+                       +----------APPOS---------+                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+-------COMP:N-N(after)-------+      
      |          +MOD_A+SUBJ:V+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-ADJ (__SP__,male)
SUBJ:V-N (miss,__SP__)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
SUBJ:V_PASS-N (involve,gland)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(after) (mRNA,treatment)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

name="reponse" value="A88">Analyse 88

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+                                                                            
      |                       +-------------------------------------------SUBJ:V_PASS-N------------------------------------------+            +-------COMP:N-N(of)-------+                                    
      +-COMP:N-N(from)-+      +-----OBJ:V-N----+----------APPOS---------+                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+-------COMP:N-N(after)-------+      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-N (__SP__,male)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
SUBJ:V_PASS-N (involve,miss)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(after) (mRNA,treatment)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

name="reponse" value="A89">Analyse 89

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+                                                                            
      |                       +-------------------------------------------SUBJ:V_PASS-N------------------------------------------+            +-------COMP:N-N(of)-------+                                    
      +-COMP:N-N(from)-+      +-----OBJ:V-N----+----------APPOS---------+                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+-------COMP:N-N(after)-------+      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-ADJ (__SP__,male)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
SUBJ:V_PASS-N (involve,miss)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(after) (mRNA,treatment)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

name="reponse" value="A90">Analyse 90

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+                                                                            
      |                +-------------------------------------------COMP:V_PASS-N(from)-------------------------------------------+                                                                            
      |                |      +-------------------------------------------SUBJ:V_PASS-N------------------------------------------+            +-------COMP:N-N(of)-------+                                    
      |                |      +-----OBJ:V-N----+----------APPOS---------+                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+-------COMP:N-N(after)-------+      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
MOD_ATT:N-N (__SP__,male)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
COMP:V_PASS-N(from) (involve,__SP__)
SUBJ:V_PASS-N (involve,miss)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(after) (mRNA,treatment)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

name="reponse" value="A91">Analyse 91

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+                                                                            
      |                +-------------------------------------------COMP:V_PASS-N(from)-------------------------------------------+                                                                            
      |                |      +-------------------------------------------SUBJ:V_PASS-N------------------------------------------+            +-------COMP:N-N(of)-------+                                    
      |                |      +-----OBJ:V-N----+----------APPOS---------+                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+-------COMP:N-N(after)-------+      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
MOD_ATT:N-ADJ (__SP__,male)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
COMP:V_PASS-N(from) (involve,__SP__)
SUBJ:V_PASS-N (involve,miss)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(after) (mRNA,treatment)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

name="reponse" value="A92">Analyse 92

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+                                                                            
      |                       +-------------------------------------------SUBJ:V_PASS-N------------------------------------------+            +-------COMP:N-N(of)-------+                                    
      +-COMP:N-N(from)-+      +-----OBJ:V-N----+----------APPOS---------+                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+-------COMP:N-N(after)-------+      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-N (__SP__,male)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
SUBJ:V_PASS-N (involve,miss)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(after) (mRNA,treatment)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

name="reponse" value="A93">Analyse 93

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+                                                                            
      |                       +-------------------------------------------SUBJ:V_PASS-N------------------------------------------+            +-------COMP:N-N(of)-------+                                    
      +-COMP:N-N(from)-+      +-----OBJ:V-N----+----------APPOS---------+                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+-------COMP:N-N(after)-------+      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-ADJ (__SP__,male)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
SUBJ:V_PASS-N (involve,miss)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(after) (mRNA,treatment)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

name="reponse" value="A94">Analyse 94

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+                                                                            
      |                +-------------------------------------------COMP:V_PASS-N(from)-------------------------------------------+                                                                            
      |                |      +-------------------------------------------SUBJ:V_PASS-N------------------------------------------+            +-------COMP:N-N(of)-------+                                    
      |                |      +-----OBJ:V-N----+----------APPOS---------+                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+-------COMP:N-N(after)-------+      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
MOD_ATT:N-N (__SP__,male)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
COMP:V_PASS-N(from) (involve,__SP__)
SUBJ:V_PASS-N (involve,miss)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(after) (mRNA,treatment)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

name="reponse" value="A95">Analyse 95

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+                                                                            
      |                +-------------------------------------------COMP:V_PASS-N(from)-------------------------------------------+                                                                            
      |                |      +-------------------------------------------SUBJ:V_PASS-N------------------------------------------+            +-------COMP:N-N(of)-------+                                    
      |                |      +-----OBJ:V-N----+----------APPOS---------+                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+-------COMP:N-N(after)-------+      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
MOD_ATT:N-ADJ (__SP__,male)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
COMP:V_PASS-N(from) (involve,__SP__)
SUBJ:V_PASS-N (involve,miss)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(after) (mRNA,treatment)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

name="reponse" value="A96">Analyse 96

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+                                                                            
      |                                                                 +----------------------SUBJ:V_PASS-N---------------------+            +-------COMP:N-N(of)-------+                                    
      +-COMP:N-N(from)-+      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+-------COMP:N-N(after)-------+      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-N (__SP__,male)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
SUBJ:V_PASS-N (involve,administration)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(after) (mRNA,treatment)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

name="reponse" value="A97">Analyse 97

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+                                                                            
      |                                                                 +----------------------SUBJ:V_PASS-N---------------------+            +-------COMP:N-N(of)-------+                                    
      +-COMP:N-N(from)-+      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+-------COMP:N-N(after)-------+      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-ADJ (__SP__,male)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
SUBJ:V_PASS-N (involve,administration)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(after) (mRNA,treatment)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

name="reponse" value="A98">Analyse 98

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+                                                                            
      |                                                                 +----------------------SUBJ:V_PASS-N---------------------+            +-------COMP:N-N(of)-------+                                    
      +-COMP:N-N(from)-+      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+-------COMP:N-N(after)-------+      
      |          +MOD_A+SUBJ:V+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-N (__SP__,male)
SUBJ:V-N (miss,__SP__)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
SUBJ:V_PASS-N (involve,administration)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(after) (mRNA,treatment)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

name="reponse" value="A99">Analyse 99

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+                                                                            
      |                                                                 +----------------------SUBJ:V_PASS-N---------------------+            +-------COMP:N-N(of)-------+                                    
      +-COMP:N-N(from)-+      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+-------COMP:N-N(after)-------+      
      |          +MOD_A+SUBJ:V+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-ADJ (__SP__,male)
SUBJ:V-N (miss,__SP__)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
SUBJ:V_PASS-N (involve,administration)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(after) (mRNA,treatment)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

name="reponse" value="A100">Analyse 100

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+                                                                            
      |                                                                 +----------------------SUBJ:V_PASS-N---------------------+            +-------COMP:N-N(of)-------+                                    
      +-COMP:N-N(from)-+      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+-------COMP:N-N(after)-------+      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-N (__SP__,male)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
SUBJ:V_PASS-N (involve,administration)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(after) (mRNA,treatment)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

name="reponse" value="A101">Analyse 101

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+                                                                            
      |                                                                 +----------------------SUBJ:V_PASS-N---------------------+            +-------COMP:N-N(of)-------+                                    
      +-COMP:N-N(from)-+      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+-------COMP:N-N(after)-------+      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-ADJ (__SP__,male)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
SUBJ:V_PASS-N (involve,administration)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(after) (mRNA,treatment)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

name="reponse" value="A102">Analyse 102

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+                                                                            
      |                                                                 +----------------------SUBJ:V_PASS-N---------------------+            +-------COMP:N-N(of)-------+                                    
      +-COMP:N-N(from)-+      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+-------COMP:N-N(after)-------+      
      |          +MOD_A+SUBJ:V+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-N (__SP__,male)
SUBJ:V-N (miss,__SP__)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
SUBJ:V_PASS-N (involve,administration)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(after) (mRNA,treatment)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

name="reponse" value="A103">Analyse 103

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+                                                                            
      |                                                                 +----------------------SUBJ:V_PASS-N---------------------+            +-------COMP:N-N(of)-------+                                    
      +-COMP:N-N(from)-+      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+-------COMP:N-N(after)-------+      
      |          +MOD_A+SUBJ:V+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-ADJ (__SP__,male)
SUBJ:V-N (miss,__SP__)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
SUBJ:V_PASS-N (involve,administration)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(after) (mRNA,treatment)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

name="reponse" value="A104">Analyse 104

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+                                                                            
      |                                        +----------------------------------SUBJ:V_PASS-N----------------------------------+            +-------COMP:N-N(of)-------+                                    
      +-COMP:N-N(from)-+                       +----------APPOS---------+                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+-------COMP:N-N(after)-------+      
      |          +MOD_A+SUBJ:V+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-N (__SP__,male)
SUBJ:V-N (miss,__SP__)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
SUBJ:V_PASS-N (involve,gland)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(after) (mRNA,treatment)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

name="reponse" value="A105">Analyse 105

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+                                                                            
      |                                        +----------------------------------SUBJ:V_PASS-N----------------------------------+            +-------COMP:N-N(of)-------+                                    
      +-COMP:N-N(from)-+                       +----------APPOS---------+                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+-------COMP:N-N(after)-------+      
      |          +MOD_A+SUBJ:V+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-ADJ (__SP__,male)
SUBJ:V-N (miss,__SP__)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
SUBJ:V_PASS-N (involve,gland)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(after) (mRNA,treatment)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

name="reponse" value="A106">Analyse 106

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+                                                                            
      |                                        +----------------------------------SUBJ:V_PASS-N----------------------------------+            +-------COMP:N-N(of)-------+                                    
      +-COMP:N-N(from)-+                       +----------APPOS---------+                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+-------COMP:N-N(after)-------+      
      |          +MOD_A+SUBJ:V+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-N (__SP__,male)
SUBJ:V-N (miss,__SP__)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
SUBJ:V_PASS-N (involve,gland)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(after) (mRNA,treatment)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

name="reponse" value="A107">Analyse 107

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+                                                                            
      |                                        +----------------------------------SUBJ:V_PASS-N----------------------------------+            +-------COMP:N-N(of)-------+                                    
      +-COMP:N-N(from)-+                       +----------APPOS---------+                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+-------COMP:N-N(after)-------+      
      |          +MOD_A+SUBJ:V+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-ADJ (__SP__,male)
SUBJ:V-N (miss,__SP__)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
SUBJ:V_PASS-N (involve,gland)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(after) (mRNA,treatment)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

name="reponse" value="A108">Analyse 108

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+                                                                            
      |                +-------------------------------------------COMP:V_PASS-N(from)-------------------------------------------+                                                                            
      |                |      +-------------------------------------------SUBJ:V_PASS-N------------------------------------------+            +-------COMP:N-N(of)-------+                                    
      |                |      +-----OBJ:V-N----+----------APPOS---------+                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+-------COMP:N-N(after)-------+      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
MOD_ATT:N-N (__SP__,male)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
COMP:V_PASS-N(from) (involve,__SP__)
SUBJ:V_PASS-N (involve,miss)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(after) (mRNA,treatment)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

name="reponse" value="A109">Analyse 109

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+                                                                            
      |                +-------------------------------------------COMP:V_PASS-N(from)-------------------------------------------+                                                                            
      |                |      +-------------------------------------------SUBJ:V_PASS-N------------------------------------------+            +-------COMP:N-N(of)-------+                                    
      |                |      +-----OBJ:V-N----+----------APPOS---------+                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+-------COMP:N-N(after)-------+      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
MOD_ATT:N-ADJ (__SP__,male)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
COMP:V_PASS-N(from) (involve,__SP__)
SUBJ:V_PASS-N (involve,miss)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(after) (mRNA,treatment)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

name="reponse" value="A110">Analyse 110

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+                                                                            
      |                +-------------------------------------------COMP:V_PASS-N(from)-------------------------------------------+                                                                            
      |                |      +-------------------------------------------SUBJ:V_PASS-N------------------------------------------+            +-------COMP:N-N(of)-------+                                    
      |                |      +-----OBJ:V-N----+----------APPOS---------+                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+-------COMP:N-N(after)-------+      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
MOD_ATT:N-N (__SP__,male)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
COMP:V_PASS-N(from) (involve,__SP__)
SUBJ:V_PASS-N (involve,miss)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(after) (mRNA,treatment)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

name="reponse" value="A111">Analyse 111

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+                                                                            
      |                +-------------------------------------------COMP:V_PASS-N(from)-------------------------------------------+                                                                            
      |                |      +-------------------------------------------SUBJ:V_PASS-N------------------------------------------+            +-------COMP:N-N(of)-------+                                    
      |                |      +-----OBJ:V-N----+----------APPOS---------+                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+-------COMP:N-N(after)-------+      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
MOD_ATT:N-ADJ (__SP__,male)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
COMP:V_PASS-N(from) (involve,__SP__)
SUBJ:V_PASS-N (involve,miss)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(after) (mRNA,treatment)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

name="reponse" value="A112">Analyse 112

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+            +---------------------COMP:N-N(after)--------------------+      
      |                       +-------------------------------------------SUBJ:V_PASS-N------------------------------------------+            +-------COMP:N-N(of)-------+                             |      
      +-COMP:N-N(from)-+      +-----OBJ:V-N----+----------APPOS---------+                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-N (__SP__,male)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
SUBJ:V_PASS-N (involve,miss)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(after) (expression,treatment)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

name="reponse" value="A113">Analyse 113

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+            +---------------------COMP:N-N(after)--------------------+      
      |                       +-------------------------------------------SUBJ:V_PASS-N------------------------------------------+            +-------COMP:N-N(of)-------+                             |      
      +-COMP:N-N(from)-+      +-----OBJ:V-N----+----------APPOS---------+                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-ADJ (__SP__,male)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
SUBJ:V_PASS-N (involve,miss)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(after) (expression,treatment)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

name="reponse" value="A114">Analyse 114

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+            +---------------------COMP:N-N(after)--------------------+      
      |                       +-------------------------------------------SUBJ:V_PASS-N------------------------------------------+            +-------COMP:N-N(of)-------+                             |      
      +-COMP:N-N(from)-+      +-----OBJ:V-N----+----------APPOS---------+                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-N (__SP__,male)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
SUBJ:V_PASS-N (involve,miss)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(after) (expression,treatment)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

name="reponse" value="A115">Analyse 115

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+            +---------------------COMP:N-N(after)--------------------+      
      |                       +-------------------------------------------SUBJ:V_PASS-N------------------------------------------+            +-------COMP:N-N(of)-------+                             |      
      +-COMP:N-N(from)-+      +-----OBJ:V-N----+----------APPOS---------+                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-ADJ (__SP__,male)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
SUBJ:V_PASS-N (involve,miss)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(after) (expression,treatment)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

name="reponse" value="A116">Analyse 116

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+                                                                            
      +--------SUBJ:V-N-------+                +----------------------------------SUBJ:V_PASS-N----------------------------------+            +-------COMP:N-N(of)-------+                                    
      +-COMP:N-N(from)-+      |                +----------APPOS---------+                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+-------COMP:N-N(after)-------+      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-N (__SP__,male)
SUBJ:V-N (miss,liver)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
SUBJ:V_PASS-N (involve,gland)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(after) (mRNA,treatment)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

name="reponse" value="A117">Analyse 117

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+                                                                            
      +--------SUBJ:V-N-------+                +----------------------------------SUBJ:V_PASS-N----------------------------------+            +-------COMP:N-N(of)-------+                                    
      +-COMP:N-N(from)-+      |                +----------APPOS---------+                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+-------COMP:N-N(after)-------+      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-ADJ (__SP__,male)
SUBJ:V-N (miss,liver)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
SUBJ:V_PASS-N (involve,gland)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(after) (mRNA,treatment)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

name="reponse" value="A118">Analyse 118

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+                                                                            
      +--------SUBJ:V-N-------+                +----------------------------------SUBJ:V_PASS-N----------------------------------+            +-------COMP:N-N(of)-------+                                    
      +-COMP:N-N(from)-+      |                +----------APPOS---------+                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+-------COMP:N-N(after)-------+      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-N (__SP__,male)
SUBJ:V-N (miss,liver)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
SUBJ:V_PASS-N (involve,gland)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(after) (mRNA,treatment)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

name="reponse" value="A119">Analyse 119

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+                                                                            
      +--------SUBJ:V-N-------+                +----------------------------------SUBJ:V_PASS-N----------------------------------+            +-------COMP:N-N(of)-------+                                    
      +-COMP:N-N(from)-+      |                +----------APPOS---------+                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+-------COMP:N-N(after)-------+      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-ADJ (__SP__,male)
SUBJ:V-N (miss,liver)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
SUBJ:V_PASS-N (involve,gland)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(after) (mRNA,treatment)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

name="reponse" value="A120">Analyse 120

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+                                                                            
      |                                                                 +----------------------SUBJ:V_PASS-N---------------------+            +-------COMP:N-N(of)-------+                                    
      +-COMP:N-N(from)-+      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+-------COMP:N-N(after)-------+      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-N (__SP__,male)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
SUBJ:V_PASS-N (involve,administration)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(after) (mRNA,treatment)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

name="reponse" value="A121">Analyse 121

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+                                                                            
      |                                                                 +----------------------SUBJ:V_PASS-N---------------------+            +-------COMP:N-N(of)-------+                                    
      +-COMP:N-N(from)-+      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+-------COMP:N-N(after)-------+      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-ADJ (__SP__,male)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
SUBJ:V_PASS-N (involve,administration)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(after) (mRNA,treatment)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

name="reponse" value="A122">Analyse 122

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+                                                                            
      |                                                                 +----------------------SUBJ:V_PASS-N---------------------+            +-------COMP:N-N(of)-------+                                    
      +-COMP:N-N(from)-+      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+-------COMP:N-N(after)-------+      
      |          +MOD_A+SUBJ:V+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-N (__SP__,male)
SUBJ:V-N (miss,__SP__)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
SUBJ:V_PASS-N (involve,administration)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(after) (mRNA,treatment)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

name="reponse" value="A123">Analyse 123

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+                                                                            
      |                                                                 +----------------------SUBJ:V_PASS-N---------------------+            +-------COMP:N-N(of)-------+                                    
      +-COMP:N-N(from)-+      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+-------COMP:N-N(after)-------+      
      |          +MOD_A+SUBJ:V+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-ADJ (__SP__,male)
SUBJ:V-N (miss,__SP__)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
SUBJ:V_PASS-N (involve,administration)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(after) (mRNA,treatment)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

name="reponse" value="A124">Analyse 124

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+                                                                            
      |                                                                 +----------------------SUBJ:V_PASS-N---------------------+            +-------COMP:N-N(of)-------+                                    
      +-COMP:N-N(from)-+      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+-------COMP:N-N(after)-------+      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-N (__SP__,male)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
SUBJ:V_PASS-N (involve,administration)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(after) (mRNA,treatment)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

name="reponse" value="A125">Analyse 125

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+                                                                            
      |                                                                 +----------------------SUBJ:V_PASS-N---------------------+            +-------COMP:N-N(of)-------+                                    
      +-COMP:N-N(from)-+      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+-------COMP:N-N(after)-------+      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-ADJ (__SP__,male)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
SUBJ:V_PASS-N (involve,administration)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(after) (mRNA,treatment)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

name="reponse" value="A126">Analyse 126

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+                                                                            
      |                                                                 +----------------------SUBJ:V_PASS-N---------------------+            +-------COMP:N-N(of)-------+                                    
      +-COMP:N-N(from)-+      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+-------COMP:N-N(after)-------+      
      |          +MOD_A+SUBJ:V+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-N (__SP__,male)
SUBJ:V-N (miss,__SP__)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
SUBJ:V_PASS-N (involve,administration)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(after) (mRNA,treatment)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

name="reponse" value="A127">Analyse 127

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+                                                                            
      |                                                                 +----------------------SUBJ:V_PASS-N---------------------+            +-------COMP:N-N(of)-------+                                    
      +-COMP:N-N(from)-+      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+-------COMP:N-N(after)-------+      
      |          +MOD_A+SUBJ:V+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-ADJ (__SP__,male)
SUBJ:V-N (miss,__SP__)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
SUBJ:V_PASS-N (involve,administration)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(after) (mRNA,treatment)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

name="reponse" value="A128">Analyse 128

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+            +---------------------COMP:N-N(after)--------------------+      
      |                                        +----------------------------------SUBJ:V_PASS-N----------------------------------+            +-------COMP:N-N(of)-------+                             |      
      +-COMP:N-N(from)-+                       +----------APPOS---------+                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+SUBJ:V+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-N (__SP__,male)
SUBJ:V-N (miss,__SP__)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
SUBJ:V_PASS-N (involve,gland)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(after) (expression,treatment)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

name="reponse" value="A129">Analyse 129

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+            +---------------------COMP:N-N(after)--------------------+      
      |                                        +----------------------------------SUBJ:V_PASS-N----------------------------------+            +-------COMP:N-N(of)-------+                             |      
      +-COMP:N-N(from)-+                       +----------APPOS---------+                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+SUBJ:V+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-ADJ (__SP__,male)
SUBJ:V-N (miss,__SP__)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
SUBJ:V_PASS-N (involve,gland)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(after) (expression,treatment)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

name="reponse" value="A130">Analyse 130

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+            +---------------------COMP:N-N(after)--------------------+      
      |                                        +----------------------------------SUBJ:V_PASS-N----------------------------------+            +-------COMP:N-N(of)-------+                             |      
      +-COMP:N-N(from)-+                       +----------APPOS---------+                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+SUBJ:V+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-N (__SP__,male)
SUBJ:V-N (miss,__SP__)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
SUBJ:V_PASS-N (involve,gland)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(after) (expression,treatment)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

name="reponse" value="A131">Analyse 131

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+            +---------------------COMP:N-N(after)--------------------+      
      |                                        +----------------------------------SUBJ:V_PASS-N----------------------------------+            +-------COMP:N-N(of)-------+                             |      
      +-COMP:N-N(from)-+                       +----------APPOS---------+                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+SUBJ:V+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-ADJ (__SP__,male)
SUBJ:V-N (miss,__SP__)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
SUBJ:V_PASS-N (involve,gland)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(after) (expression,treatment)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

name="reponse" value="A132">Analyse 132

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+                                                                            
      +--------SUBJ:V-N-------+                                         +----------------------SUBJ:V_PASS-N---------------------+            +-------COMP:N-N(of)-------+                                    
      +-COMP:N-N(from)-+      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+-------COMP:N-N(after)-------+      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-N (__SP__,male)
SUBJ:V-N (miss,liver)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
SUBJ:V_PASS-N (involve,administration)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(after) (mRNA,treatment)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

name="reponse" value="A133">Analyse 133

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+                                                                            
      +--------SUBJ:V-N-------+                                         +----------------------SUBJ:V_PASS-N---------------------+            +-------COMP:N-N(of)-------+                                    
      +-COMP:N-N(from)-+      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+-------COMP:N-N(after)-------+      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-ADJ (__SP__,male)
SUBJ:V-N (miss,liver)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
SUBJ:V_PASS-N (involve,administration)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(after) (mRNA,treatment)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

name="reponse" value="A134">Analyse 134

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+                                                                            
      +--------SUBJ:V-N-------+                                         +----------------------SUBJ:V_PASS-N---------------------+            +-------COMP:N-N(of)-------+                                    
      +-COMP:N-N(from)-+      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+-------COMP:N-N(after)-------+      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-N (__SP__,male)
SUBJ:V-N (miss,liver)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
SUBJ:V_PASS-N (involve,administration)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(after) (mRNA,treatment)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

name="reponse" value="A135">Analyse 135

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+                                                                            
      +--------SUBJ:V-N-------+                                         +----------------------SUBJ:V_PASS-N---------------------+            +-------COMP:N-N(of)-------+                                    
      +-COMP:N-N(from)-+      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+-------COMP:N-N(after)-------+      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-ADJ (__SP__,male)
SUBJ:V-N (miss,liver)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
SUBJ:V_PASS-N (involve,administration)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(after) (mRNA,treatment)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

name="reponse" value="A136">Analyse 136

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+            +---------------------COMP:N-N(after)--------------------+      
      |                       +-------------------------------------------SUBJ:V_PASS-N------------------------------------------+            +-------COMP:N-N(of)-------+                             |      
      +-COMP:N-N(from)-+      +-----OBJ:V-N----+----------APPOS---------+                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-N (__SP__,male)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
SUBJ:V_PASS-N (involve,miss)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(after) (expression,treatment)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

name="reponse" value="A137">Analyse 137

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+            +---------------------COMP:N-N(after)--------------------+      
      |                       +-------------------------------------------SUBJ:V_PASS-N------------------------------------------+            +-------COMP:N-N(of)-------+                             |      
      +-COMP:N-N(from)-+      +-----OBJ:V-N----+----------APPOS---------+                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-ADJ (__SP__,male)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
SUBJ:V_PASS-N (involve,miss)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(after) (expression,treatment)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

name="reponse" value="A138">Analyse 138

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+                                                                            
      |                +-------------------------------------------COMP:V_PASS-N(from)-------------------------------------------+            +---------------------COMP:N-N(after)--------------------+      
      |                |      +-------------------------------------------SUBJ:V_PASS-N------------------------------------------+            +-------COMP:N-N(of)-------+                             |      
      |                |      +-----OBJ:V-N----+----------APPOS---------+                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
MOD_ATT:N-N (__SP__,male)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
COMP:V_PASS-N(from) (involve,__SP__)
SUBJ:V_PASS-N (involve,miss)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(after) (expression,treatment)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

name="reponse" value="A139">Analyse 139

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+                                                                            
      |                +-------------------------------------------COMP:V_PASS-N(from)-------------------------------------------+            +---------------------COMP:N-N(after)--------------------+      
      |                |      +-------------------------------------------SUBJ:V_PASS-N------------------------------------------+            +-------COMP:N-N(of)-------+                             |      
      |                |      +-----OBJ:V-N----+----------APPOS---------+                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
MOD_ATT:N-ADJ (__SP__,male)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
COMP:V_PASS-N(from) (involve,__SP__)
SUBJ:V_PASS-N (involve,miss)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(after) (expression,treatment)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

name="reponse" value="A140">Analyse 140

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+            +---------------------COMP:N-N(after)--------------------+      
      |                       +-------------------------------------------SUBJ:V_PASS-N------------------------------------------+            +-------COMP:N-N(of)-------+                             |      
      +-COMP:N-N(from)-+      +-----OBJ:V-N----+----------APPOS---------+                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-N (__SP__,male)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
SUBJ:V_PASS-N (involve,miss)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(after) (expression,treatment)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

name="reponse" value="A141">Analyse 141

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+            +---------------------COMP:N-N(after)--------------------+      
      |                       +-------------------------------------------SUBJ:V_PASS-N------------------------------------------+            +-------COMP:N-N(of)-------+                             |      
      +-COMP:N-N(from)-+      +-----OBJ:V-N----+----------APPOS---------+                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-ADJ (__SP__,male)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
SUBJ:V_PASS-N (involve,miss)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(after) (expression,treatment)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

name="reponse" value="A142">Analyse 142

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+                                                                            
      |                +-------------------------------------------COMP:V_PASS-N(from)-------------------------------------------+            +---------------------COMP:N-N(after)--------------------+      
      |                |      +-------------------------------------------SUBJ:V_PASS-N------------------------------------------+            +-------COMP:N-N(of)-------+                             |      
      |                |      +-----OBJ:V-N----+----------APPOS---------+                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
MOD_ATT:N-N (__SP__,male)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
COMP:V_PASS-N(from) (involve,__SP__)
SUBJ:V_PASS-N (involve,miss)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(after) (expression,treatment)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

name="reponse" value="A143">Analyse 143

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+                                                                            
      |                +-------------------------------------------COMP:V_PASS-N(from)-------------------------------------------+            +---------------------COMP:N-N(after)--------------------+      
      |                |      +-------------------------------------------SUBJ:V_PASS-N------------------------------------------+            +-------COMP:N-N(of)-------+                             |      
      |                |      +-----OBJ:V-N----+----------APPOS---------+                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
MOD_ATT:N-ADJ (__SP__,male)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
COMP:V_PASS-N(from) (involve,__SP__)
SUBJ:V_PASS-N (involve,miss)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(after) (expression,treatment)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

name="reponse" value="A144">Analyse 144

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+                                                                            
      +--------SUBJ:V-N-------+                +----------------------------------SUBJ:V_PASS-N----------------------------------+            +-------COMP:N-N(of)-------+                                    
      +-COMP:N-N(from)-+      |                +----------APPOS---------+                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+-------COMP:N-N(after)-------+      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-N (__SP__,male)
SUBJ:V-N (miss,liver)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
SUBJ:V_PASS-N (involve,gland)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(after) (mRNA,treatment)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

name="reponse" value="A145">Analyse 145

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+                                                                            
      +--------SUBJ:V-N-------+                +----------------------------------SUBJ:V_PASS-N----------------------------------+            +-------COMP:N-N(of)-------+                                    
      +-COMP:N-N(from)-+      |                +----------APPOS---------+                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+-------COMP:N-N(after)-------+      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-ADJ (__SP__,male)
SUBJ:V-N (miss,liver)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
SUBJ:V_PASS-N (involve,gland)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(after) (mRNA,treatment)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

name="reponse" value="A146">Analyse 146

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+                                                                            
      |                +-------------------------------------------COMP:V_PASS-N(from)-------------------------------------------+                                                                            
      |                |                       +----------------------------------SUBJ:V_PASS-N----------------------------------+            +-------COMP:N-N(of)-------+                                    
      |                |                       +----------APPOS---------+                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+-------COMP:N-N(after)-------+      
      |          +MOD_A+SUBJ:V+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
MOD_ATT:N-N (__SP__,male)
SUBJ:V-N (miss,__SP__)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
COMP:V_PASS-N(from) (involve,__SP__)
SUBJ:V_PASS-N (involve,gland)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(after) (mRNA,treatment)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

name="reponse" value="A147">Analyse 147

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+                                                                            
      |                +-------------------------------------------COMP:V_PASS-N(from)-------------------------------------------+                                                                            
      |                |                       +----------------------------------SUBJ:V_PASS-N----------------------------------+            +-------COMP:N-N(of)-------+                                    
      |                |                       +----------APPOS---------+                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+-------COMP:N-N(after)-------+      
      |          +MOD_A+SUBJ:V+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
MOD_ATT:N-ADJ (__SP__,male)
SUBJ:V-N (miss,__SP__)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
COMP:V_PASS-N(from) (involve,__SP__)
SUBJ:V_PASS-N (involve,gland)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(after) (mRNA,treatment)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

name="reponse" value="A148">Analyse 148

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+                                                                            
      +--------SUBJ:V-N-------+                +----------------------------------SUBJ:V_PASS-N----------------------------------+            +-------COMP:N-N(of)-------+                                    
      +-COMP:N-N(from)-+      |                +----------APPOS---------+                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+-------COMP:N-N(after)-------+      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-N (__SP__,male)
SUBJ:V-N (miss,liver)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
SUBJ:V_PASS-N (involve,gland)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(after) (mRNA,treatment)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

name="reponse" value="A149">Analyse 149

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+                                                                            
      +--------SUBJ:V-N-------+                +----------------------------------SUBJ:V_PASS-N----------------------------------+            +-------COMP:N-N(of)-------+                                    
      +-COMP:N-N(from)-+      |                +----------APPOS---------+                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+-------COMP:N-N(after)-------+      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-ADJ (__SP__,male)
SUBJ:V-N (miss,liver)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
SUBJ:V_PASS-N (involve,gland)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(after) (mRNA,treatment)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

name="reponse" value="A150">Analyse 150

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+                                                                            
      |                +-------------------------------------------COMP:V_PASS-N(from)-------------------------------------------+                                                                            
      |                |                       +----------------------------------SUBJ:V_PASS-N----------------------------------+            +-------COMP:N-N(of)-------+                                    
      |                |                       +----------APPOS---------+                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+-------COMP:N-N(after)-------+      
      |          +MOD_A+SUBJ:V+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
MOD_ATT:N-N (__SP__,male)
SUBJ:V-N (miss,__SP__)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
COMP:V_PASS-N(from) (involve,__SP__)
SUBJ:V_PASS-N (involve,gland)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(after) (mRNA,treatment)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

name="reponse" value="A151">Analyse 151

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+                                                                            
      |                +-------------------------------------------COMP:V_PASS-N(from)-------------------------------------------+                                                                            
      |                |                       +----------------------------------SUBJ:V_PASS-N----------------------------------+            +-------COMP:N-N(of)-------+                                    
      |                |                       +----------APPOS---------+                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+-------COMP:N-N(after)-------+      
      |          +MOD_A+SUBJ:V+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
MOD_ATT:N-ADJ (__SP__,male)
SUBJ:V-N (miss,__SP__)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
COMP:V_PASS-N(from) (involve,__SP__)
SUBJ:V_PASS-N (involve,gland)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(after) (mRNA,treatment)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

name="reponse" value="A152">Analyse 152

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+            +---------------------COMP:N-N(after)--------------------+      
      |                                                                 +----------------------SUBJ:V_PASS-N---------------------+            +-------COMP:N-N(of)-------+                             |      
      +-COMP:N-N(from)-+      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-N (__SP__,male)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
SUBJ:V_PASS-N (involve,administration)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(after) (expression,treatment)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

name="reponse" value="A153">Analyse 153

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+            +---------------------COMP:N-N(after)--------------------+      
      |                                                                 +----------------------SUBJ:V_PASS-N---------------------+            +-------COMP:N-N(of)-------+                             |      
      +-COMP:N-N(from)-+      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-ADJ (__SP__,male)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
SUBJ:V_PASS-N (involve,administration)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(after) (expression,treatment)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

name="reponse" value="A154">Analyse 154

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+            +---------------------COMP:N-N(after)--------------------+      
      |                                                                 +----------------------SUBJ:V_PASS-N---------------------+            +-------COMP:N-N(of)-------+                             |      
      +-COMP:N-N(from)-+      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+SUBJ:V+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-N (__SP__,male)
SUBJ:V-N (miss,__SP__)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
SUBJ:V_PASS-N (involve,administration)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(after) (expression,treatment)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

name="reponse" value="A155">Analyse 155

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+            +---------------------COMP:N-N(after)--------------------+      
      |                                                                 +----------------------SUBJ:V_PASS-N---------------------+            +-------COMP:N-N(of)-------+                             |      
      +-COMP:N-N(from)-+      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+SUBJ:V+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-ADJ (__SP__,male)
SUBJ:V-N (miss,__SP__)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
SUBJ:V_PASS-N (involve,administration)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(after) (expression,treatment)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

name="reponse" value="A156">Analyse 156

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+            +---------------------COMP:N-N(after)--------------------+      
      |                                                                 +----------------------SUBJ:V_PASS-N---------------------+            +-------COMP:N-N(of)-------+                             |      
      +-COMP:N-N(from)-+      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-N (__SP__,male)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
SUBJ:V_PASS-N (involve,administration)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(after) (expression,treatment)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

name="reponse" value="A157">Analyse 157

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+            +---------------------COMP:N-N(after)--------------------+      
      |                                                                 +----------------------SUBJ:V_PASS-N---------------------+            +-------COMP:N-N(of)-------+                             |      
      +-COMP:N-N(from)-+      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-ADJ (__SP__,male)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
SUBJ:V_PASS-N (involve,administration)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(after) (expression,treatment)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

name="reponse" value="A158">Analyse 158

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+            +---------------------COMP:N-N(after)--------------------+      
      |                                                                 +----------------------SUBJ:V_PASS-N---------------------+            +-------COMP:N-N(of)-------+                             |      
      +-COMP:N-N(from)-+      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+SUBJ:V+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-N (__SP__,male)
SUBJ:V-N (miss,__SP__)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
SUBJ:V_PASS-N (involve,administration)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(after) (expression,treatment)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

name="reponse" value="A159">Analyse 159

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+            +---------------------COMP:N-N(after)--------------------+      
      |                                                                 +----------------------SUBJ:V_PASS-N---------------------+            +-------COMP:N-N(of)-------+                             |      
      +-COMP:N-N(from)-+      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+SUBJ:V+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-ADJ (__SP__,male)
SUBJ:V-N (miss,__SP__)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
SUBJ:V_PASS-N (involve,administration)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(after) (expression,treatment)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

name="reponse" value="A160">Analyse 160

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+            +---------------------COMP:N-N(after)--------------------+      
      |                                        +----------------------------------SUBJ:V_PASS-N----------------------------------+            +-------COMP:N-N(of)-------+                             |      
      +-COMP:N-N(from)-+                       +----------APPOS---------+                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+SUBJ:V+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-N (__SP__,male)
SUBJ:V-N (miss,__SP__)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
SUBJ:V_PASS-N (involve,gland)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(after) (expression,treatment)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

name="reponse" value="A161">Analyse 161

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+            +---------------------COMP:N-N(after)--------------------+      
      |                                        +----------------------------------SUBJ:V_PASS-N----------------------------------+            +-------COMP:N-N(of)-------+                             |      
      +-COMP:N-N(from)-+                       +----------APPOS---------+                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+SUBJ:V+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-ADJ (__SP__,male)
SUBJ:V-N (miss,__SP__)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
SUBJ:V_PASS-N (involve,gland)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(after) (expression,treatment)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

name="reponse" value="A162">Analyse 162

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+            +---------------------COMP:N-N(after)--------------------+      
      |                                        +----------------------------------SUBJ:V_PASS-N----------------------------------+            +-------COMP:N-N(of)-------+                             |      
      +-COMP:N-N(from)-+                       +----------APPOS---------+                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+SUBJ:V+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-N (__SP__,male)
SUBJ:V-N (miss,__SP__)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
SUBJ:V_PASS-N (involve,gland)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(after) (expression,treatment)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

name="reponse" value="A163">Analyse 163

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+            +---------------------COMP:N-N(after)--------------------+      
      |                                        +----------------------------------SUBJ:V_PASS-N----------------------------------+            +-------COMP:N-N(of)-------+                             |      
      +-COMP:N-N(from)-+                       +----------APPOS---------+                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+SUBJ:V+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-ADJ (__SP__,male)
SUBJ:V-N (miss,__SP__)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
SUBJ:V_PASS-N (involve,gland)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(after) (expression,treatment)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

name="reponse" value="A164">Analyse 164

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+                                                                            
      +--------SUBJ:V-N-------+                                         +----------------------SUBJ:V_PASS-N---------------------+            +-------COMP:N-N(of)-------+                                    
      +-COMP:N-N(from)-+      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+-------COMP:N-N(after)-------+      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-N (__SP__,male)
SUBJ:V-N (miss,liver)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
SUBJ:V_PASS-N (involve,administration)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(after) (mRNA,treatment)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

name="reponse" value="A165">Analyse 165

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+                                                                            
      +--------SUBJ:V-N-------+                                         +----------------------SUBJ:V_PASS-N---------------------+            +-------COMP:N-N(of)-------+                                    
      +-COMP:N-N(from)-+      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+-------COMP:N-N(after)-------+      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-ADJ (__SP__,male)
SUBJ:V-N (miss,liver)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
SUBJ:V_PASS-N (involve,administration)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(after) (mRNA,treatment)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

name="reponse" value="A166">Analyse 166

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+                                                                            
      +--------SUBJ:V-N-------+                                         +----------------------SUBJ:V_PASS-N---------------------+            +-------COMP:N-N(of)-------+                                    
      +-COMP:N-N(from)-+      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+-------COMP:N-N(after)-------+      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-N (__SP__,male)
SUBJ:V-N (miss,liver)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
SUBJ:V_PASS-N (involve,administration)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(after) (mRNA,treatment)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

name="reponse" value="A167">Analyse 167

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+                                                                            
      +--------SUBJ:V-N-------+                                         +----------------------SUBJ:V_PASS-N---------------------+            +-------COMP:N-N(of)-------+                                    
      +-COMP:N-N(from)-+      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+-------COMP:N-N(after)-------+      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-ADJ (__SP__,male)
SUBJ:V-N (miss,liver)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
SUBJ:V_PASS-N (involve,administration)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(after) (mRNA,treatment)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

name="reponse" value="A168">Analyse 168

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+                                                                            
      |                +-------------------------------------------COMP:V_PASS-N(from)-------------------------------------------+            +---------------------COMP:N-N(after)--------------------+      
      |                |      +-------------------------------------------SUBJ:V_PASS-N------------------------------------------+            +-------COMP:N-N(of)-------+                             |      
      |                |      +-----OBJ:V-N----+----------APPOS---------+                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
MOD_ATT:N-N (__SP__,male)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
COMP:V_PASS-N(from) (involve,__SP__)
SUBJ:V_PASS-N (involve,miss)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(after) (expression,treatment)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

name="reponse" value="A169">Analyse 169

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+                                                                            
      |                +-------------------------------------------COMP:V_PASS-N(from)-------------------------------------------+            +---------------------COMP:N-N(after)--------------------+      
      |                |      +-------------------------------------------SUBJ:V_PASS-N------------------------------------------+            +-------COMP:N-N(of)-------+                             |      
      |                |      +-----OBJ:V-N----+----------APPOS---------+                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
MOD_ATT:N-ADJ (__SP__,male)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
COMP:V_PASS-N(from) (involve,__SP__)
SUBJ:V_PASS-N (involve,miss)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(after) (expression,treatment)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

name="reponse" value="A170">Analyse 170

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+                                                                            
      |                +-------------------------------------------COMP:V_PASS-N(from)-------------------------------------------+            +---------------------COMP:N-N(after)--------------------+      
      |                |      +-------------------------------------------SUBJ:V_PASS-N------------------------------------------+            +-------COMP:N-N(of)-------+                             |      
      |                |      +-----OBJ:V-N----+----------APPOS---------+                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
MOD_ATT:N-N (__SP__,male)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
COMP:V_PASS-N(from) (involve,__SP__)
SUBJ:V_PASS-N (involve,miss)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(after) (expression,treatment)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

name="reponse" value="A171">Analyse 171

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+                                                                            
      |                +-------------------------------------------COMP:V_PASS-N(from)-------------------------------------------+            +---------------------COMP:N-N(after)--------------------+      
      |                |      +-------------------------------------------SUBJ:V_PASS-N------------------------------------------+            +-------COMP:N-N(of)-------+                             |      
      |                |      +-----OBJ:V-N----+----------APPOS---------+                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
MOD_ATT:N-ADJ (__SP__,male)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
COMP:V_PASS-N(from) (involve,__SP__)
SUBJ:V_PASS-N (involve,miss)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(after) (expression,treatment)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

name="reponse" value="A172">Analyse 172

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+                                                                            
      |                +-------------------------------------------COMP:V_PASS-N(from)-------------------------------------------+                                                                            
      |                |                       +----------------------------------SUBJ:V_PASS-N----------------------------------+            +-------COMP:N-N(of)-------+                                    
      |                |                       +----------APPOS---------+                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+-------COMP:N-N(after)-------+      
      |          +MOD_A+SUBJ:V+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
MOD_ATT:N-N (__SP__,male)
SUBJ:V-N (miss,__SP__)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
COMP:V_PASS-N(from) (involve,__SP__)
SUBJ:V_PASS-N (involve,gland)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(after) (mRNA,treatment)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

name="reponse" value="A173">Analyse 173

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+                                                                            
      |                +-------------------------------------------COMP:V_PASS-N(from)-------------------------------------------+                                                                            
      |                |                       +----------------------------------SUBJ:V_PASS-N----------------------------------+            +-------COMP:N-N(of)-------+                                    
      |                |                       +----------APPOS---------+                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+-------COMP:N-N(after)-------+      
      |          +MOD_A+SUBJ:V+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
MOD_ATT:N-ADJ (__SP__,male)
SUBJ:V-N (miss,__SP__)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
COMP:V_PASS-N(from) (involve,__SP__)
SUBJ:V_PASS-N (involve,gland)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(after) (mRNA,treatment)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

name="reponse" value="A174">Analyse 174

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+                                                                            
      |                +-------------------------------------------COMP:V_PASS-N(from)-------------------------------------------+                                                                            
      |                |                       +----------------------------------SUBJ:V_PASS-N----------------------------------+            +-------COMP:N-N(of)-------+                                    
      |                |                       +----------APPOS---------+                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+-------COMP:N-N(after)-------+      
      |          +MOD_A+SUBJ:V+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
MOD_ATT:N-N (__SP__,male)
SUBJ:V-N (miss,__SP__)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
COMP:V_PASS-N(from) (involve,__SP__)
SUBJ:V_PASS-N (involve,gland)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(after) (mRNA,treatment)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

name="reponse" value="A175">Analyse 175

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+                                                                            
      |                +-------------------------------------------COMP:V_PASS-N(from)-------------------------------------------+                                                                            
      |                |                       +----------------------------------SUBJ:V_PASS-N----------------------------------+            +-------COMP:N-N(of)-------+                                    
      |                |                       +----------APPOS---------+                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+-------COMP:N-N(after)-------+      
      |          +MOD_A+SUBJ:V+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
MOD_ATT:N-ADJ (__SP__,male)
SUBJ:V-N (miss,__SP__)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
COMP:V_PASS-N(from) (involve,__SP__)
SUBJ:V_PASS-N (involve,gland)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(after) (mRNA,treatment)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

name="reponse" value="A176">Analyse 176

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+            +---------------------COMP:N-N(after)--------------------+      
      +--------SUBJ:V-N-------+                +----------------------------------SUBJ:V_PASS-N----------------------------------+            +-------COMP:N-N(of)-------+                             |      
      +-COMP:N-N(from)-+      |                +----------APPOS---------+                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-N (__SP__,male)
SUBJ:V-N (miss,liver)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
SUBJ:V_PASS-N (involve,gland)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(after) (expression,treatment)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

name="reponse" value="A177">Analyse 177

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+            +---------------------COMP:N-N(after)--------------------+      
      +--------SUBJ:V-N-------+                +----------------------------------SUBJ:V_PASS-N----------------------------------+            +-------COMP:N-N(of)-------+                             |      
      +-COMP:N-N(from)-+      |                +----------APPOS---------+                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-ADJ (__SP__,male)
SUBJ:V-N (miss,liver)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
SUBJ:V_PASS-N (involve,gland)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(after) (expression,treatment)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

name="reponse" value="A178">Analyse 178

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+            +---------------------COMP:N-N(after)--------------------+      
      +--------SUBJ:V-N-------+                +----------------------------------SUBJ:V_PASS-N----------------------------------+            +-------COMP:N-N(of)-------+                             |      
      +-COMP:N-N(from)-+      |                +----------APPOS---------+                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-N (__SP__,male)
SUBJ:V-N (miss,liver)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
SUBJ:V_PASS-N (involve,gland)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(after) (expression,treatment)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

name="reponse" value="A179">Analyse 179

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+            +---------------------COMP:N-N(after)--------------------+      
      +--------SUBJ:V-N-------+                +----------------------------------SUBJ:V_PASS-N----------------------------------+            +-------COMP:N-N(of)-------+                             |      
      +-COMP:N-N(from)-+      |                +----------APPOS---------+                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-ADJ (__SP__,male)
SUBJ:V-N (miss,liver)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
SUBJ:V_PASS-N (involve,gland)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(after) (expression,treatment)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

name="reponse" value="A180">Analyse 180

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+            +---------------------COMP:N-N(after)--------------------+      
      |                                                                 +----------------------SUBJ:V_PASS-N---------------------+            +-------COMP:N-N(of)-------+                             |      
      +-COMP:N-N(from)-+      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-N (__SP__,male)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
SUBJ:V_PASS-N (involve,administration)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(after) (expression,treatment)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

name="reponse" value="A181">Analyse 181

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+            +---------------------COMP:N-N(after)--------------------+      
      |                                                                 +----------------------SUBJ:V_PASS-N---------------------+            +-------COMP:N-N(of)-------+                             |      
      +-COMP:N-N(from)-+      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-ADJ (__SP__,male)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
SUBJ:V_PASS-N (involve,administration)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(after) (expression,treatment)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

name="reponse" value="A182">Analyse 182

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+            +---------------------COMP:N-N(after)--------------------+      
      |                                                                 +----------------------SUBJ:V_PASS-N---------------------+            +-------COMP:N-N(of)-------+                             |      
      +-COMP:N-N(from)-+      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+SUBJ:V+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-N (__SP__,male)
SUBJ:V-N (miss,__SP__)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
SUBJ:V_PASS-N (involve,administration)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(after) (expression,treatment)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

name="reponse" value="A183">Analyse 183

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+            +---------------------COMP:N-N(after)--------------------+      
      |                                                                 +----------------------SUBJ:V_PASS-N---------------------+            +-------COMP:N-N(of)-------+                             |      
      +-COMP:N-N(from)-+      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+SUBJ:V+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-ADJ (__SP__,male)
SUBJ:V-N (miss,__SP__)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
SUBJ:V_PASS-N (involve,administration)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(after) (expression,treatment)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

name="reponse" value="A184">Analyse 184

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+            +---------------------COMP:N-N(after)--------------------+      
      |                                                                 +----------------------SUBJ:V_PASS-N---------------------+            +-------COMP:N-N(of)-------+                             |      
      +-COMP:N-N(from)-+      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-N (__SP__,male)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
SUBJ:V_PASS-N (involve,administration)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(after) (expression,treatment)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

name="reponse" value="A185">Analyse 185

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+            +---------------------COMP:N-N(after)--------------------+      
      |                                                                 +----------------------SUBJ:V_PASS-N---------------------+            +-------COMP:N-N(of)-------+                             |      
      +-COMP:N-N(from)-+      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-ADJ (__SP__,male)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
SUBJ:V_PASS-N (involve,administration)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(after) (expression,treatment)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

name="reponse" value="A186">Analyse 186

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+            +---------------------COMP:N-N(after)--------------------+      
      |                                                                 +----------------------SUBJ:V_PASS-N---------------------+            +-------COMP:N-N(of)-------+                             |      
      +-COMP:N-N(from)-+      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+SUBJ:V+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-N (__SP__,male)
SUBJ:V-N (miss,__SP__)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
SUBJ:V_PASS-N (involve,administration)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(after) (expression,treatment)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

name="reponse" value="A187">Analyse 187

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+            +---------------------COMP:N-N(after)--------------------+      
      |                                                                 +----------------------SUBJ:V_PASS-N---------------------+            +-------COMP:N-N(of)-------+                             |      
      +-COMP:N-N(from)-+      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+SUBJ:V+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-ADJ (__SP__,male)
SUBJ:V-N (miss,__SP__)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
SUBJ:V_PASS-N (involve,administration)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(after) (expression,treatment)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

name="reponse" value="A188">Analyse 188

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+                                                                            
      |                +-------------------------------------------COMP:V_PASS-N(from)-------------------------------------------+                                                                            
      |                |                                                +----------------------SUBJ:V_PASS-N---------------------+            +-------COMP:N-N(of)-------+                                    
      |                |      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+-------COMP:N-N(after)-------+      
      |          +MOD_A+SUBJ:V+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
MOD_ATT:N-N (__SP__,male)
SUBJ:V-N (miss,__SP__)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
COMP:V_PASS-N(from) (involve,__SP__)
SUBJ:V_PASS-N (involve,administration)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(after) (mRNA,treatment)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

name="reponse" value="A189">Analyse 189

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+                                                                            
      |                +-------------------------------------------COMP:V_PASS-N(from)-------------------------------------------+                                                                            
      |                |                                                +----------------------SUBJ:V_PASS-N---------------------+            +-------COMP:N-N(of)-------+                                    
      |                |      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+-------COMP:N-N(after)-------+      
      |          +MOD_A+SUBJ:V+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
MOD_ATT:N-ADJ (__SP__,male)
SUBJ:V-N (miss,__SP__)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
COMP:V_PASS-N(from) (involve,__SP__)
SUBJ:V_PASS-N (involve,administration)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(after) (mRNA,treatment)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

name="reponse" value="A190">Analyse 190

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+                                                                            
      |                +-------------------------------------------COMP:V_PASS-N(from)-------------------------------------------+                                                                            
      |                |                                                +----------------------SUBJ:V_PASS-N---------------------+            +-------COMP:N-N(of)-------+                                    
      |                |      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+-------COMP:N-N(after)-------+      
      |          +MOD_A+SUBJ:V+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
MOD_ATT:N-N (__SP__,male)
SUBJ:V-N (miss,__SP__)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
COMP:V_PASS-N(from) (involve,__SP__)
SUBJ:V_PASS-N (involve,administration)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(after) (mRNA,treatment)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

name="reponse" value="A191">Analyse 191

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+                                                                            
      |                +-------------------------------------------COMP:V_PASS-N(from)-------------------------------------------+                                                                            
      |                |                                                +----------------------SUBJ:V_PASS-N---------------------+            +-------COMP:N-N(of)-------+                                    
      |                |      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+-------COMP:N-N(after)-------+      
      |          +MOD_A+SUBJ:V+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
MOD_ATT:N-ADJ (__SP__,male)
SUBJ:V-N (miss,__SP__)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
COMP:V_PASS-N(from) (involve,__SP__)
SUBJ:V_PASS-N (involve,administration)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(after) (mRNA,treatment)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

name="reponse" value="A192">Analyse 192

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+            +---------------------COMP:N-N(after)--------------------+      
      +--------SUBJ:V-N-------+                                         +----------------------SUBJ:V_PASS-N---------------------+            +-------COMP:N-N(of)-------+                             |      
      +-COMP:N-N(from)-+      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-N (__SP__,male)
SUBJ:V-N (miss,liver)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
SUBJ:V_PASS-N (involve,administration)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(after) (expression,treatment)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

name="reponse" value="A193">Analyse 193

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+            +---------------------COMP:N-N(after)--------------------+      
      +--------SUBJ:V-N-------+                                         +----------------------SUBJ:V_PASS-N---------------------+            +-------COMP:N-N(of)-------+                             |      
      +-COMP:N-N(from)-+      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-ADJ (__SP__,male)
SUBJ:V-N (miss,liver)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
SUBJ:V_PASS-N (involve,administration)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(after) (expression,treatment)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

name="reponse" value="A194">Analyse 194

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+            +---------------------COMP:N-N(after)--------------------+      
      +--------SUBJ:V-N-------+                                         +----------------------SUBJ:V_PASS-N---------------------+            +-------COMP:N-N(of)-------+                             |      
      +-COMP:N-N(from)-+      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-N (__SP__,male)
SUBJ:V-N (miss,liver)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
SUBJ:V_PASS-N (involve,administration)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(after) (expression,treatment)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

name="reponse" value="A195">Analyse 195

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+            +---------------------COMP:N-N(after)--------------------+      
      +--------SUBJ:V-N-------+                                         +----------------------SUBJ:V_PASS-N---------------------+            +-------COMP:N-N(of)-------+                             |      
      +-COMP:N-N(from)-+      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-ADJ (__SP__,male)
SUBJ:V-N (miss,liver)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
SUBJ:V_PASS-N (involve,administration)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(after) (expression,treatment)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

name="reponse" value="A196">Analyse 196

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+            +---------------------COMP:N-N(after)--------------------+      
      +--------SUBJ:V-N-------+                +----------------------------------SUBJ:V_PASS-N----------------------------------+            +-------COMP:N-N(of)-------+                             |      
      +-COMP:N-N(from)-+      |                +----------APPOS---------+                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-N (__SP__,male)
SUBJ:V-N (miss,liver)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
SUBJ:V_PASS-N (involve,gland)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(after) (expression,treatment)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

name="reponse" value="A197">Analyse 197

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+            +---------------------COMP:N-N(after)--------------------+      
      +--------SUBJ:V-N-------+                +----------------------------------SUBJ:V_PASS-N----------------------------------+            +-------COMP:N-N(of)-------+                             |      
      +-COMP:N-N(from)-+      |                +----------APPOS---------+                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-ADJ (__SP__,male)
SUBJ:V-N (miss,liver)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
SUBJ:V_PASS-N (involve,gland)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(after) (expression,treatment)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

name="reponse" value="A198">Analyse 198

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+                                                                            
      |                +-------------------------------------------COMP:V_PASS-N(from)-------------------------------------------+            +---------------------COMP:N-N(after)--------------------+      
      |                |                       +----------------------------------SUBJ:V_PASS-N----------------------------------+            +-------COMP:N-N(of)-------+                             |      
      |                |                       +----------APPOS---------+                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+SUBJ:V+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
MOD_ATT:N-N (__SP__,male)
SUBJ:V-N (miss,__SP__)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
COMP:V_PASS-N(from) (involve,__SP__)
SUBJ:V_PASS-N (involve,gland)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(after) (expression,treatment)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

name="reponse" value="A199">Analyse 199

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+                                                                            
      |                +-------------------------------------------COMP:V_PASS-N(from)-------------------------------------------+            +---------------------COMP:N-N(after)--------------------+      
      |                |                       +----------------------------------SUBJ:V_PASS-N----------------------------------+            +-------COMP:N-N(of)-------+                             |      
      |                |                       +----------APPOS---------+                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+SUBJ:V+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
MOD_ATT:N-ADJ (__SP__,male)
SUBJ:V-N (miss,__SP__)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
COMP:V_PASS-N(from) (involve,__SP__)
SUBJ:V_PASS-N (involve,gland)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(after) (expression,treatment)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

name="reponse" value="A200">Analyse 200

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+            +---------------------COMP:N-N(after)--------------------+      
      +--------SUBJ:V-N-------+                +----------------------------------SUBJ:V_PASS-N----------------------------------+            +-------COMP:N-N(of)-------+                             |      
      +-COMP:N-N(from)-+      |                +----------APPOS---------+                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-N (__SP__,male)
SUBJ:V-N (miss,liver)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
SUBJ:V_PASS-N (involve,gland)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(after) (expression,treatment)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

name="reponse" value="A201">Analyse 201

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+            +---------------------COMP:N-N(after)--------------------+      
      +--------SUBJ:V-N-------+                +----------------------------------SUBJ:V_PASS-N----------------------------------+            +-------COMP:N-N(of)-------+                             |      
      +-COMP:N-N(from)-+      |                +----------APPOS---------+                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-ADJ (__SP__,male)
SUBJ:V-N (miss,liver)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
SUBJ:V_PASS-N (involve,gland)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(after) (expression,treatment)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

name="reponse" value="A202">Analyse 202

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+                                                                            
      |                +-------------------------------------------COMP:V_PASS-N(from)-------------------------------------------+            +---------------------COMP:N-N(after)--------------------+      
      |                |                       +----------------------------------SUBJ:V_PASS-N----------------------------------+            +-------COMP:N-N(of)-------+                             |      
      |                |                       +----------APPOS---------+                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+SUBJ:V+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
MOD_ATT:N-N (__SP__,male)
SUBJ:V-N (miss,__SP__)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
COMP:V_PASS-N(from) (involve,__SP__)
SUBJ:V_PASS-N (involve,gland)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(after) (expression,treatment)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

name="reponse" value="A203">Analyse 203

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+                                                                            
      |                +-------------------------------------------COMP:V_PASS-N(from)-------------------------------------------+            +---------------------COMP:N-N(after)--------------------+      
      |                |                       +----------------------------------SUBJ:V_PASS-N----------------------------------+            +-------COMP:N-N(of)-------+                             |      
      |                |                       +----------APPOS---------+                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+SUBJ:V+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
MOD_ATT:N-ADJ (__SP__,male)
SUBJ:V-N (miss,__SP__)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
COMP:V_PASS-N(from) (involve,__SP__)
SUBJ:V_PASS-N (involve,gland)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(after) (expression,treatment)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

name="reponse" value="A204">Analyse 204

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+                                                                            
      |                +-------------------------------------------COMP:V_PASS-N(from)-------------------------------------------+                                                                            
      |                |                                                +----------------------SUBJ:V_PASS-N---------------------+            +-------COMP:N-N(of)-------+                                    
      |                |      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+-------COMP:N-N(after)-------+      
      |          +MOD_A+SUBJ:V+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
MOD_ATT:N-N (__SP__,male)
SUBJ:V-N (miss,__SP__)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
COMP:V_PASS-N(from) (involve,__SP__)
SUBJ:V_PASS-N (involve,administration)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(after) (mRNA,treatment)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

name="reponse" value="A205">Analyse 205

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+                                                                            
      |                +-------------------------------------------COMP:V_PASS-N(from)-------------------------------------------+                                                                            
      |                |                                                +----------------------SUBJ:V_PASS-N---------------------+            +-------COMP:N-N(of)-------+                                    
      |                |      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+-------COMP:N-N(after)-------+      
      |          +MOD_A+SUBJ:V+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
MOD_ATT:N-ADJ (__SP__,male)
SUBJ:V-N (miss,__SP__)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
COMP:V_PASS-N(from) (involve,__SP__)
SUBJ:V_PASS-N (involve,administration)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(after) (mRNA,treatment)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

name="reponse" value="A206">Analyse 206

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+                                                                            
      |                +-------------------------------------------COMP:V_PASS-N(from)-------------------------------------------+                                                                            
      |                |                                                +----------------------SUBJ:V_PASS-N---------------------+            +-------COMP:N-N(of)-------+                                    
      |                |      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+-------COMP:N-N(after)-------+      
      |          +MOD_A+SUBJ:V+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
MOD_ATT:N-N (__SP__,male)
SUBJ:V-N (miss,__SP__)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
COMP:V_PASS-N(from) (involve,__SP__)
SUBJ:V_PASS-N (involve,administration)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(after) (mRNA,treatment)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

name="reponse" value="A207">Analyse 207

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+                                                                            
      |                +-------------------------------------------COMP:V_PASS-N(from)-------------------------------------------+                                                                            
      |                |                                                +----------------------SUBJ:V_PASS-N---------------------+            +-------COMP:N-N(of)-------+                                    
      |                |      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+-------COMP:N-N(after)-------+      
      |          +MOD_A+SUBJ:V+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
MOD_ATT:N-ADJ (__SP__,male)
SUBJ:V-N (miss,__SP__)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
COMP:V_PASS-N(from) (involve,__SP__)
SUBJ:V_PASS-N (involve,administration)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(after) (mRNA,treatment)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

name="reponse" value="A208">Analyse 208

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+                                                                            
      |                +-------------------------------------------COMP:V_PASS-N(from)-------------------------------------------+                                                                            
      |                |                                                +----------------------SUBJ:V_PASS-N---------------------+            +-------COMP:N-N(of)-------+                                    
      |                |      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+-------COMP:N-N(after)-------+      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
MOD_ATT:N-N (__SP__,male)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
COMP:V_PASS-N(from) (involve,__SP__)
SUBJ:V_PASS-N (involve,administration)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(after) (mRNA,treatment)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

name="reponse" value="A209">Analyse 209

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+                                                                            
      |                +-------------------------------------------COMP:V_PASS-N(from)-------------------------------------------+                                                                            
      |                |                                                +----------------------SUBJ:V_PASS-N---------------------+            +-------COMP:N-N(of)-------+                                    
      |                |      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+-------COMP:N-N(after)-------+      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
MOD_ATT:N-ADJ (__SP__,male)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
COMP:V_PASS-N(from) (involve,__SP__)
SUBJ:V_PASS-N (involve,administration)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(after) (mRNA,treatment)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

name="reponse" value="A210">Analyse 210

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+                                                                            
      |                +-------------------------------------------COMP:V_PASS-N(from)-------------------------------------------+                                                                            
      |                |                                                +----------------------SUBJ:V_PASS-N---------------------+            +-------COMP:N-N(of)-------+                                    
      |                |      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+-------COMP:N-N(after)-------+      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
MOD_ATT:N-N (__SP__,male)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
COMP:V_PASS-N(from) (involve,__SP__)
SUBJ:V_PASS-N (involve,administration)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(after) (mRNA,treatment)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

name="reponse" value="A211">Analyse 211

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+                                                                            
      |                +-------------------------------------------COMP:V_PASS-N(from)-------------------------------------------+                                                                            
      |                |                                                +----------------------SUBJ:V_PASS-N---------------------+            +-------COMP:N-N(of)-------+                                    
      |                |      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+-------COMP:N-N(after)-------+      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
MOD_ATT:N-ADJ (__SP__,male)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
COMP:V_PASS-N(from) (involve,__SP__)
SUBJ:V_PASS-N (involve,administration)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(after) (mRNA,treatment)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

name="reponse" value="A212">Analyse 212

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+            +---------------------COMP:N-N(after)--------------------+      
      +--------SUBJ:V-N-------+                                         +----------------------SUBJ:V_PASS-N---------------------+            +-------COMP:N-N(of)-------+                             |      
      +-COMP:N-N(from)-+      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-N (__SP__,male)
SUBJ:V-N (miss,liver)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
SUBJ:V_PASS-N (involve,administration)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(after) (expression,treatment)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

name="reponse" value="A213">Analyse 213

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+            +---------------------COMP:N-N(after)--------------------+      
      +--------SUBJ:V-N-------+                                         +----------------------SUBJ:V_PASS-N---------------------+            +-------COMP:N-N(of)-------+                             |      
      +-COMP:N-N(from)-+      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-ADJ (__SP__,male)
SUBJ:V-N (miss,liver)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
SUBJ:V_PASS-N (involve,administration)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(after) (expression,treatment)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

name="reponse" value="A214">Analyse 214

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+            +---------------------COMP:N-N(after)--------------------+      
      +--------SUBJ:V-N-------+                                         +----------------------SUBJ:V_PASS-N---------------------+            +-------COMP:N-N(of)-------+                             |      
      +-COMP:N-N(from)-+      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-N (__SP__,male)
SUBJ:V-N (miss,liver)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
SUBJ:V_PASS-N (involve,administration)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(after) (expression,treatment)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

name="reponse" value="A215">Analyse 215

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+            +---------------------COMP:N-N(after)--------------------+      
      +--------SUBJ:V-N-------+                                         +----------------------SUBJ:V_PASS-N---------------------+            +-------COMP:N-N(of)-------+                             |      
      +-COMP:N-N(from)-+      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-ADJ (__SP__,male)
SUBJ:V-N (miss,liver)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
SUBJ:V_PASS-N (involve,administration)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(after) (expression,treatment)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

name="reponse" value="A216">Analyse 216

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+                                                                            
      |                +-------------------------------------------COMP:V_PASS-N(from)-------------------------------------------+            +---------------------COMP:N-N(after)--------------------+      
      |                |                       +----------------------------------SUBJ:V_PASS-N----------------------------------+            +-------COMP:N-N(of)-------+                             |      
      |                |                       +----------APPOS---------+                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+SUBJ:V+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
MOD_ATT:N-N (__SP__,male)
SUBJ:V-N (miss,__SP__)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
COMP:V_PASS-N(from) (involve,__SP__)
SUBJ:V_PASS-N (involve,gland)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(after) (expression,treatment)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

name="reponse" value="A217">Analyse 217

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+                                                                            
      |                +-------------------------------------------COMP:V_PASS-N(from)-------------------------------------------+            +---------------------COMP:N-N(after)--------------------+      
      |                |                       +----------------------------------SUBJ:V_PASS-N----------------------------------+            +-------COMP:N-N(of)-------+                             |      
      |                |                       +----------APPOS---------+                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+SUBJ:V+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
MOD_ATT:N-ADJ (__SP__,male)
SUBJ:V-N (miss,__SP__)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
COMP:V_PASS-N(from) (involve,__SP__)
SUBJ:V_PASS-N (involve,gland)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(after) (expression,treatment)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

name="reponse" value="A218">Analyse 218

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+                                                                            
      |                +-------------------------------------------COMP:V_PASS-N(from)-------------------------------------------+            +---------------------COMP:N-N(after)--------------------+      
      |                |                       +----------------------------------SUBJ:V_PASS-N----------------------------------+            +-------COMP:N-N(of)-------+                             |      
      |                |                       +----------APPOS---------+                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+SUBJ:V+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
MOD_ATT:N-N (__SP__,male)
SUBJ:V-N (miss,__SP__)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
COMP:V_PASS-N(from) (involve,__SP__)
SUBJ:V_PASS-N (involve,gland)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(after) (expression,treatment)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

name="reponse" value="A219">Analyse 219

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+                                                                            
      |                +-------------------------------------------COMP:V_PASS-N(from)-------------------------------------------+            +---------------------COMP:N-N(after)--------------------+      
      |                |                       +----------------------------------SUBJ:V_PASS-N----------------------------------+            +-------COMP:N-N(of)-------+                             |      
      |                |                       +----------APPOS---------+                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+SUBJ:V+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
MOD_ATT:N-ADJ (__SP__,male)
SUBJ:V-N (miss,__SP__)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
COMP:V_PASS-N(from) (involve,__SP__)
SUBJ:V_PASS-N (involve,gland)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(after) (expression,treatment)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

name="reponse" value="A220">Analyse 220

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+                                                                            
      |                +-------------------------------------------COMP:V_PASS-N(from)-------------------------------------------+                                                                            
      |                |                                                +----------------------SUBJ:V_PASS-N---------------------+            +-------COMP:N-N(of)-------+                                    
      |                |      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+-------COMP:N-N(after)-------+      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
MOD_ATT:N-N (__SP__,male)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
COMP:V_PASS-N(from) (involve,__SP__)
SUBJ:V_PASS-N (involve,administration)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(after) (mRNA,treatment)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

name="reponse" value="A221">Analyse 221

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+                                                                            
      |                +-------------------------------------------COMP:V_PASS-N(from)-------------------------------------------+                                                                            
      |                |                                                +----------------------SUBJ:V_PASS-N---------------------+            +-------COMP:N-N(of)-------+                                    
      |                |      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+-------COMP:N-N(after)-------+      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
MOD_ATT:N-ADJ (__SP__,male)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
COMP:V_PASS-N(from) (involve,__SP__)
SUBJ:V_PASS-N (involve,administration)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(after) (mRNA,treatment)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

name="reponse" value="A222">Analyse 222

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+                                                                            
      |                +-------------------------------------------COMP:V_PASS-N(from)-------------------------------------------+                                                                            
      |                |                                                +----------------------SUBJ:V_PASS-N---------------------+            +-------COMP:N-N(of)-------+                                    
      |                |      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+-------COMP:N-N(after)-------+      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
MOD_ATT:N-N (__SP__,male)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
COMP:V_PASS-N(from) (involve,__SP__)
SUBJ:V_PASS-N (involve,administration)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(after) (mRNA,treatment)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

name="reponse" value="A223">Analyse 223

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+                                                                            
      |                +-------------------------------------------COMP:V_PASS-N(from)-------------------------------------------+                                                                            
      |                |                                                +----------------------SUBJ:V_PASS-N---------------------+            +-------COMP:N-N(of)-------+                                    
      |                |      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+-------COMP:N-N(after)-------+      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
MOD_ATT:N-ADJ (__SP__,male)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
COMP:V_PASS-N(from) (involve,__SP__)
SUBJ:V_PASS-N (involve,administration)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(after) (mRNA,treatment)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

name="reponse" value="A224">Analyse 224

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+                                                                            
      |                +-------------------------------------------COMP:V_PASS-N(from)-------------------------------------------+            +---------------------COMP:N-N(after)--------------------+      
      |                |                                                +----------------------SUBJ:V_PASS-N---------------------+            +-------COMP:N-N(of)-------+                             |      
      |                |      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+SUBJ:V+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
MOD_ATT:N-N (__SP__,male)
SUBJ:V-N (miss,__SP__)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
COMP:V_PASS-N(from) (involve,__SP__)
SUBJ:V_PASS-N (involve,administration)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(after) (expression,treatment)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

name="reponse" value="A225">Analyse 225

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+                                                                            
      |                +-------------------------------------------COMP:V_PASS-N(from)-------------------------------------------+            +---------------------COMP:N-N(after)--------------------+      
      |                |                                                +----------------------SUBJ:V_PASS-N---------------------+            +-------COMP:N-N(of)-------+                             |      
      |                |      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+SUBJ:V+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
MOD_ATT:N-ADJ (__SP__,male)
SUBJ:V-N (miss,__SP__)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
COMP:V_PASS-N(from) (involve,__SP__)
SUBJ:V_PASS-N (involve,administration)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(after) (expression,treatment)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

name="reponse" value="A226">Analyse 226

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+                                                                            
      |                +-------------------------------------------COMP:V_PASS-N(from)-------------------------------------------+            +---------------------COMP:N-N(after)--------------------+      
      |                |                                                +----------------------SUBJ:V_PASS-N---------------------+            +-------COMP:N-N(of)-------+                             |      
      |                |      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+SUBJ:V+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
MOD_ATT:N-N (__SP__,male)
SUBJ:V-N (miss,__SP__)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
COMP:V_PASS-N(from) (involve,__SP__)
SUBJ:V_PASS-N (involve,administration)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(after) (expression,treatment)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

name="reponse" value="A227">Analyse 227

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+                                                                            
      |                +-------------------------------------------COMP:V_PASS-N(from)-------------------------------------------+            +---------------------COMP:N-N(after)--------------------+      
      |                |                                                +----------------------SUBJ:V_PASS-N---------------------+            +-------COMP:N-N(of)-------+                             |      
      |                |      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+SUBJ:V+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
MOD_ATT:N-ADJ (__SP__,male)
SUBJ:V-N (miss,__SP__)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
COMP:V_PASS-N(from) (involve,__SP__)
SUBJ:V_PASS-N (involve,administration)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(after) (expression,treatment)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

name="reponse" value="A228">Analyse 228

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+                                                                            
      |                +-------------------------------------------COMP:V_PASS-N(from)-------------------------------------------+            +---------------------COMP:N-N(after)--------------------+      
      |                |                                                +----------------------SUBJ:V_PASS-N---------------------+            +-------COMP:N-N(of)-------+                             |      
      |                |      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+SUBJ:V+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
MOD_ATT:N-N (__SP__,male)
SUBJ:V-N (miss,__SP__)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
COMP:V_PASS-N(from) (involve,__SP__)
SUBJ:V_PASS-N (involve,administration)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(after) (expression,treatment)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

name="reponse" value="A229">Analyse 229

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+                                                                            
      |                +-------------------------------------------COMP:V_PASS-N(from)-------------------------------------------+            +---------------------COMP:N-N(after)--------------------+      
      |                |                                                +----------------------SUBJ:V_PASS-N---------------------+            +-------COMP:N-N(of)-------+                             |      
      |                |      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+SUBJ:V+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
MOD_ATT:N-ADJ (__SP__,male)
SUBJ:V-N (miss,__SP__)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
COMP:V_PASS-N(from) (involve,__SP__)
SUBJ:V_PASS-N (involve,administration)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(after) (expression,treatment)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

name="reponse" value="A230">Analyse 230

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+                                                                            
      |                +-------------------------------------------COMP:V_PASS-N(from)-------------------------------------------+            +---------------------COMP:N-N(after)--------------------+      
      |                |                                                +----------------------SUBJ:V_PASS-N---------------------+            +-------COMP:N-N(of)-------+                             |      
      |                |      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+SUBJ:V+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
MOD_ATT:N-N (__SP__,male)
SUBJ:V-N (miss,__SP__)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
COMP:V_PASS-N(from) (involve,__SP__)
SUBJ:V_PASS-N (involve,administration)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(after) (expression,treatment)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

name="reponse" value="A231">Analyse 231

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+                                                                            
      |                +-------------------------------------------COMP:V_PASS-N(from)-------------------------------------------+            +---------------------COMP:N-N(after)--------------------+      
      |                |                                                +----------------------SUBJ:V_PASS-N---------------------+            +-------COMP:N-N(of)-------+                             |      
      |                |      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+SUBJ:V+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
MOD_ATT:N-ADJ (__SP__,male)
SUBJ:V-N (miss,__SP__)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
COMP:V_PASS-N(from) (involve,__SP__)
SUBJ:V_PASS-N (involve,administration)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(after) (expression,treatment)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

name="reponse" value="A232">Analyse 232

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+                                                                            
      |                +-------------------------------------------COMP:V_PASS-N(from)-------------------------------------------+            +---------------------COMP:N-N(after)--------------------+      
      |                |                                                +----------------------SUBJ:V_PASS-N---------------------+            +-------COMP:N-N(of)-------+                             |      
      |                |      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
MOD_ATT:N-N (__SP__,male)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
COMP:V_PASS-N(from) (involve,__SP__)
SUBJ:V_PASS-N (involve,administration)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(after) (expression,treatment)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

name="reponse" value="A233">Analyse 233

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+                                                                            
      |                +-------------------------------------------COMP:V_PASS-N(from)-------------------------------------------+            +---------------------COMP:N-N(after)--------------------+      
      |                |                                                +----------------------SUBJ:V_PASS-N---------------------+            +-------COMP:N-N(of)-------+                             |      
      |                |      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
MOD_ATT:N-ADJ (__SP__,male)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
COMP:V_PASS-N(from) (involve,__SP__)
SUBJ:V_PASS-N (involve,administration)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(after) (expression,treatment)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

name="reponse" value="A234">Analyse 234

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+                                                                            
      |                +-------------------------------------------COMP:V_PASS-N(from)-------------------------------------------+            +---------------------COMP:N-N(after)--------------------+      
      |                |                                                +----------------------SUBJ:V_PASS-N---------------------+            +-------COMP:N-N(of)-------+                             |      
      |                |      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
MOD_ATT:N-N (__SP__,male)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
COMP:V_PASS-N(from) (involve,__SP__)
SUBJ:V_PASS-N (involve,administration)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(after) (expression,treatment)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

name="reponse" value="A235">Analyse 235

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+                                                                            
      |                +-------------------------------------------COMP:V_PASS-N(from)-------------------------------------------+            +---------------------COMP:N-N(after)--------------------+      
      |                |                                                +----------------------SUBJ:V_PASS-N---------------------+            +-------COMP:N-N(of)-------+                             |      
      |                |      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
MOD_ATT:N-ADJ (__SP__,male)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
COMP:V_PASS-N(from) (involve,__SP__)
SUBJ:V_PASS-N (involve,administration)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(after) (expression,treatment)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

name="reponse" value="A236">Analyse 236

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+                                                                            
      |                +-------------------------------------------COMP:V_PASS-N(from)-------------------------------------------+            +---------------------COMP:N-N(after)--------------------+      
      |                |                                                +----------------------SUBJ:V_PASS-N---------------------+            +-------COMP:N-N(of)-------+                             |      
      |                |      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
MOD_ATT:N-N (__SP__,male)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
COMP:V_PASS-N(from) (involve,__SP__)
SUBJ:V_PASS-N (involve,administration)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(after) (expression,treatment)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

name="reponse" value="A237">Analyse 237

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+                                                                            
      |                +-------------------------------------------COMP:V_PASS-N(from)-------------------------------------------+            +---------------------COMP:N-N(after)--------------------+      
      |                |                                                +----------------------SUBJ:V_PASS-N---------------------+            +-------COMP:N-N(of)-------+                             |      
      |                |      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
MOD_ATT:N-ADJ (__SP__,male)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
COMP:V_PASS-N(from) (involve,__SP__)
SUBJ:V_PASS-N (involve,administration)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(after) (expression,treatment)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

name="reponse" value="A238">Analyse 238

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+                                                                            
      |                +-------------------------------------------COMP:V_PASS-N(from)-------------------------------------------+            +---------------------COMP:N-N(after)--------------------+      
      |                |                                                +----------------------SUBJ:V_PASS-N---------------------+            +-------COMP:N-N(of)-------+                             |      
      |                |      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
MOD_ATT:N-N (__SP__,male)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
COMP:V_PASS-N(from) (involve,__SP__)
SUBJ:V_PASS-N (involve,administration)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(after) (expression,treatment)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

name="reponse" value="A239">Analyse 239

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+                                                                            
      |                +-------------------------------------------COMP:V_PASS-N(from)-------------------------------------------+            +---------------------COMP:N-N(after)--------------------+      
      |                |                                                +----------------------SUBJ:V_PASS-N---------------------+            +-------COMP:N-N(of)-------+                             |      
      |                |      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
MOD_ATT:N-ADJ (__SP__,male)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
COMP:V_PASS-N(from) (involve,__SP__)
SUBJ:V_PASS-N (involve,administration)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(after) (expression,treatment)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

name="reponse" value="A240">Analyse 240

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+-------------------------COMP:V_PASS-N(after)------------------------+      
      +-----COMP:N-N(from)----+                +----------------------------------SUBJ:V_PASS-N----------------------------------+            +-------COMP:N-N(of)-------+                             |      
      |          +MOD_ATT:N-AD+                +----------APPOS---------+                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+                             |      
      |          |     +MOD_AT+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,miss)
MOD_ATT:N-ADJ (miss,male)
MOD_ATT:N-ADJ (miss,__SP__)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
SUBJ:V_PASS-N (involve,gland)
COMP:V_PASS-N(in) (involve,expression)
COMP:V_PASS-N(after) (involve,treatment)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

name="reponse" value="A241">Analyse 241

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+-------------------------COMP:V_PASS-N(after)------------------------+      
      +-----COMP:N-N(from)----+                +----------------------------------SUBJ:V_PASS-N----------------------------------+            +-------COMP:N-N(of)-------+                             |      
      |          +MOD_ATT:N-AD+                +----------APPOS---------+                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+                             |      
      |          |     +MOD_AT+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,miss)
MOD_ATT:N-ADJ (miss,male)
MOD_ATT:N-ADJ (miss,__SP__)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
SUBJ:V_PASS-N (involve,gland)
COMP:V_PASS-N(in) (involve,expression)
COMP:V_PASS-N(after) (involve,treatment)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

name="reponse" value="A242">Analyse 242

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+-------------------------COMP:V_PASS-N(after)------------------------+      
      +-----COMP:N-N(from)----+                +----------------------------------SUBJ:V_PASS-N----------------------------------+            +-------COMP:N-N(of)-------+                             |      
      |          +MOD_ATT:N-AD+                +----------APPOS---------+                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+                             |      
      |          |     +MOD_AT+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,miss)
MOD_ATT:N-ADJ (miss,male)
MOD_ATT:N-ADJ (miss,__SP__)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
SUBJ:V_PASS-N (involve,gland)
COMP:V_PASS-N(in) (involve,expression)
COMP:V_PASS-N(after) (involve,treatment)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

name="reponse" value="A243">Analyse 243

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+-------------------------COMP:V_PASS-N(after)------------------------+      
      +-----COMP:N-N(from)----+                +----------------------------------SUBJ:V_PASS-N----------------------------------+            +-------COMP:N-N(of)-------+                             |      
      |          +MOD_ATT:N-AD+                +----------APPOS---------+                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+                             |      
      |          |     +MOD_AT+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,miss)
MOD_ATT:N-ADJ (miss,male)
MOD_ATT:N-ADJ (miss,__SP__)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
SUBJ:V_PASS-N (involve,gland)
COMP:V_PASS-N(in) (involve,expression)
COMP:V_PASS-N(after) (involve,treatment)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

name="reponse" value="A244">Analyse 244

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+                                                                            
      |                       +----------------------------------------COMP:V_PASS-N(from)---------------------------------------+-------------------------COMP:V_PASS-N(after)------------------------+      
      |                       |                +----------------------------------SUBJ:V_PASS-N----------------------------------+            +-------COMP:N-N(of)-------+                             |      
      |          +MOD_ATT:N-AD+                +----------APPOS---------+                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+                             |      
      |          |     +MOD_AT+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
MOD_ATT:N-ADJ (miss,male)
MOD_ATT:N-ADJ (miss,__SP__)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
COMP:V_PASS-N(from) (involve,miss)
SUBJ:V_PASS-N (involve,gland)
COMP:V_PASS-N(in) (involve,expression)
COMP:V_PASS-N(after) (involve,treatment)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

name="reponse" value="A245">Analyse 245

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+                                                                            
      |                       +----------------------------------------COMP:V_PASS-N(from)---------------------------------------+-------------------------COMP:V_PASS-N(after)------------------------+      
      |                       |                +----------------------------------SUBJ:V_PASS-N----------------------------------+            +-------COMP:N-N(of)-------+                             |      
      |          +MOD_ATT:N-AD+                +----------APPOS---------+                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+                             |      
      |          |     +MOD_AT+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
MOD_ATT:N-ADJ (miss,male)
MOD_ATT:N-ADJ (miss,__SP__)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
COMP:V_PASS-N(from) (involve,miss)
SUBJ:V_PASS-N (involve,gland)
COMP:V_PASS-N(in) (involve,expression)
COMP:V_PASS-N(after) (involve,treatment)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

name="reponse" value="A246">Analyse 246

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+                                                                            
      |                       +----------------------------------------COMP:V_PASS-N(from)---------------------------------------+-------------------------COMP:V_PASS-N(after)------------------------+      
      |                       |                +----------------------------------SUBJ:V_PASS-N----------------------------------+            +-------COMP:N-N(of)-------+                             |      
      |          +MOD_ATT:N-AD+                +----------APPOS---------+                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+                             |      
      |          |     +MOD_AT+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
MOD_ATT:N-ADJ (miss,male)
MOD_ATT:N-ADJ (miss,__SP__)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
COMP:V_PASS-N(from) (involve,miss)
SUBJ:V_PASS-N (involve,gland)
COMP:V_PASS-N(in) (involve,expression)
COMP:V_PASS-N(after) (involve,treatment)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

name="reponse" value="A247">Analyse 247

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+                                                                            
      |                       +----------------------------------------COMP:V_PASS-N(from)---------------------------------------+-------------------------COMP:V_PASS-N(after)------------------------+      
      |                       |                +----------------------------------SUBJ:V_PASS-N----------------------------------+            +-------COMP:N-N(of)-------+                             |      
      |          +MOD_ATT:N-AD+                +----------APPOS---------+                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+                             |      
      |          |     +MOD_AT+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
MOD_ATT:N-ADJ (miss,male)
MOD_ATT:N-ADJ (miss,__SP__)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
COMP:V_PASS-N(from) (involve,miss)
SUBJ:V_PASS-N (involve,gland)
COMP:V_PASS-N(in) (involve,expression)
COMP:V_PASS-N(after) (involve,treatment)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

name="reponse" value="A248">Analyse 248

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+                                                                            
      +-----COMP:N-N(from)----+                +----------------------------------SUBJ:V_PASS-N----------------------------------+            +-------COMP:N-N(of)-------+                                    
      |          +MOD_ATT:N-AD+                +----------APPOS---------+                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+-------COMP:N-N(after)-------+      
      |          |     +MOD_AT+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,miss)
MOD_ATT:N-ADJ (miss,male)
MOD_ATT:N-ADJ (miss,__SP__)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
SUBJ:V_PASS-N (involve,gland)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(after) (mRNA,treatment)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

name="reponse" value="A249">Analyse 249

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+                                                                            
      +-----COMP:N-N(from)----+                +----------------------------------SUBJ:V_PASS-N----------------------------------+            +-------COMP:N-N(of)-------+                                    
      |          +MOD_ATT:N-AD+                +----------APPOS---------+                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+-------COMP:N-N(after)-------+      
      |          |     +MOD_AT+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,miss)
MOD_ATT:N-ADJ (miss,male)
MOD_ATT:N-ADJ (miss,__SP__)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
SUBJ:V_PASS-N (involve,gland)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(after) (mRNA,treatment)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

name="reponse" value="A250">Analyse 250

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+                                                                            
      +-----COMP:N-N(from)----+                +----------------------------------SUBJ:V_PASS-N----------------------------------+            +-------COMP:N-N(of)-------+                                    
      |          +MOD_ATT:N-AD+                +----------APPOS---------+                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+-------COMP:N-N(after)-------+      
      |          |     +MOD_AT+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,miss)
MOD_ATT:N-ADJ (miss,male)
MOD_ATT:N-ADJ (miss,__SP__)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
SUBJ:V_PASS-N (involve,gland)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(after) (mRNA,treatment)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

name="reponse" value="A251">Analyse 251

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+                                                                            
      +-----COMP:N-N(from)----+                +----------------------------------SUBJ:V_PASS-N----------------------------------+            +-------COMP:N-N(of)-------+                                    
      |          +MOD_ATT:N-AD+                +----------APPOS---------+                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+-------COMP:N-N(after)-------+      
      |          |     +MOD_AT+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,miss)
MOD_ATT:N-ADJ (miss,male)
MOD_ATT:N-ADJ (miss,__SP__)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
SUBJ:V_PASS-N (involve,gland)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(after) (mRNA,treatment)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

name="reponse" value="A252">Analyse 252

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+            +---------------------COMP:N-N(after)--------------------+      
      +-----COMP:N-N(from)----+                +----------------------------------SUBJ:V_PASS-N----------------------------------+            +-------COMP:N-N(of)-------+                             |      
      |          +MOD_ATT:N-AD+                +----------APPOS---------+                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+                             |      
      |          |     +MOD_AT+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,miss)
MOD_ATT:N-ADJ (miss,male)
MOD_ATT:N-ADJ (miss,__SP__)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
SUBJ:V_PASS-N (involve,gland)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(after) (expression,treatment)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

name="reponse" value="A253">Analyse 253

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+            +---------------------COMP:N-N(after)--------------------+      
      +-----COMP:N-N(from)----+                +----------------------------------SUBJ:V_PASS-N----------------------------------+            +-------COMP:N-N(of)-------+                             |      
      |          +MOD_ATT:N-AD+                +----------APPOS---------+                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+                             |      
      |          |     +MOD_AT+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,miss)
MOD_ATT:N-ADJ (miss,male)
MOD_ATT:N-ADJ (miss,__SP__)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
SUBJ:V_PASS-N (involve,gland)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(after) (expression,treatment)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

name="reponse" value="A254">Analyse 254

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+                                                                            
      |                       +----------------------------------------COMP:V_PASS-N(from)---------------------------------------+                                                                            
      |                       |                +----------------------------------SUBJ:V_PASS-N----------------------------------+            +-------COMP:N-N(of)-------+                                    
      |          +MOD_ATT:N-AD+                +----------APPOS---------+                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+-------COMP:N-N(after)-------+      
      |          |     +MOD_AT+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
MOD_ATT:N-ADJ (miss,male)
MOD_ATT:N-ADJ (miss,__SP__)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
COMP:V_PASS-N(from) (involve,miss)
SUBJ:V_PASS-N (involve,gland)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(after) (mRNA,treatment)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

name="reponse" value="A255">Analyse 255

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+                                                                            
      |                       +----------------------------------------COMP:V_PASS-N(from)---------------------------------------+                                                                            
      |                       |                +----------------------------------SUBJ:V_PASS-N----------------------------------+            +-------COMP:N-N(of)-------+                                    
      |          +MOD_ATT:N-AD+                +----------APPOS---------+                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+-------COMP:N-N(after)-------+      
      |          |     +MOD_AT+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
MOD_ATT:N-ADJ (miss,male)
MOD_ATT:N-ADJ (miss,__SP__)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
COMP:V_PASS-N(from) (involve,miss)
SUBJ:V_PASS-N (involve,gland)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(after) (mRNA,treatment)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

name="reponse" value="A256">Analyse 256

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+            +---------------------COMP:N-N(after)--------------------+      
      +-----COMP:N-N(from)----+                +----------------------------------SUBJ:V_PASS-N----------------------------------+            +-------COMP:N-N(of)-------+                             |      
      |          +MOD_ATT:N-AD+                +----------APPOS---------+                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+                             |      
      |          |     +MOD_AT+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,miss)
MOD_ATT:N-ADJ (miss,male)
MOD_ATT:N-ADJ (miss,__SP__)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
SUBJ:V_PASS-N (involve,gland)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(after) (expression,treatment)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

name="reponse" value="A257">Analyse 257

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+            +---------------------COMP:N-N(after)--------------------+      
      +-----COMP:N-N(from)----+                +----------------------------------SUBJ:V_PASS-N----------------------------------+            +-------COMP:N-N(of)-------+                             |      
      |          +MOD_ATT:N-AD+                +----------APPOS---------+                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+                             |      
      |          |     +MOD_AT+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,miss)
MOD_ATT:N-ADJ (miss,male)
MOD_ATT:N-ADJ (miss,__SP__)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
SUBJ:V_PASS-N (involve,gland)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(after) (expression,treatment)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

name="reponse" value="A258">Analyse 258

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+                                                                            
      |                       +----------------------------------------COMP:V_PASS-N(from)---------------------------------------+                                                                            
      |                       |                +----------------------------------SUBJ:V_PASS-N----------------------------------+            +-------COMP:N-N(of)-------+                                    
      |          +MOD_ATT:N-AD+                +----------APPOS---------+                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+-------COMP:N-N(after)-------+      
      |          |     +MOD_AT+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
MOD_ATT:N-ADJ (miss,male)
MOD_ATT:N-ADJ (miss,__SP__)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
COMP:V_PASS-N(from) (involve,miss)
SUBJ:V_PASS-N (involve,gland)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(after) (mRNA,treatment)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

name="reponse" value="A259">Analyse 259

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+                                                                            
      |                       +----------------------------------------COMP:V_PASS-N(from)---------------------------------------+                                                                            
      |                       |                +----------------------------------SUBJ:V_PASS-N----------------------------------+            +-------COMP:N-N(of)-------+                                    
      |          +MOD_ATT:N-AD+                +----------APPOS---------+                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+-------COMP:N-N(after)-------+      
      |          |     +MOD_AT+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
MOD_ATT:N-ADJ (miss,male)
MOD_ATT:N-ADJ (miss,__SP__)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
COMP:V_PASS-N(from) (involve,miss)
SUBJ:V_PASS-N (involve,gland)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(after) (mRNA,treatment)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

name="reponse" value="A260">Analyse 260

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+                                                                            
      |                       +----------------------------------------COMP:V_PASS-N(from)---------------------------------------+            +---------------------COMP:N-N(after)--------------------+      
      |                       |                +----------------------------------SUBJ:V_PASS-N----------------------------------+            +-------COMP:N-N(of)-------+                             |      
      |          +MOD_ATT:N-AD+                +----------APPOS---------+                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+                             |      
      |          |     +MOD_AT+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
MOD_ATT:N-ADJ (miss,male)
MOD_ATT:N-ADJ (miss,__SP__)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
COMP:V_PASS-N(from) (involve,miss)
SUBJ:V_PASS-N (involve,gland)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(after) (expression,treatment)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

name="reponse" value="A261">Analyse 261

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+                                                                            
      |                       +----------------------------------------COMP:V_PASS-N(from)---------------------------------------+            +---------------------COMP:N-N(after)--------------------+      
      |                       |                +----------------------------------SUBJ:V_PASS-N----------------------------------+            +-------COMP:N-N(of)-------+                             |      
      |          +MOD_ATT:N-AD+                +----------APPOS---------+                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+                             |      
      |          |     +MOD_AT+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
MOD_ATT:N-ADJ (miss,male)
MOD_ATT:N-ADJ (miss,__SP__)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
COMP:V_PASS-N(from) (involve,miss)
SUBJ:V_PASS-N (involve,gland)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(after) (expression,treatment)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

name="reponse" value="A262">Analyse 262

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+                                                                            
      |                       +----------------------------------------COMP:V_PASS-N(from)---------------------------------------+            +---------------------COMP:N-N(after)--------------------+      
      |                       |                +----------------------------------SUBJ:V_PASS-N----------------------------------+            +-------COMP:N-N(of)-------+                             |      
      |          +MOD_ATT:N-AD+                +----------APPOS---------+                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+                             |      
      |          |     +MOD_AT+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
MOD_ATT:N-ADJ (miss,male)
MOD_ATT:N-ADJ (miss,__SP__)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
COMP:V_PASS-N(from) (involve,miss)
SUBJ:V_PASS-N (involve,gland)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(after) (expression,treatment)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

name="reponse" value="A263">Analyse 263

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+                                                                            
      |                       +----------------------------------------COMP:V_PASS-N(from)---------------------------------------+            +---------------------COMP:N-N(after)--------------------+      
      |                       |                +----------------------------------SUBJ:V_PASS-N----------------------------------+            +-------COMP:N-N(of)-------+                             |      
      |          +MOD_ATT:N-AD+                +----------APPOS---------+                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+                             |      
      |          |     +MOD_AT+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
MOD_ATT:N-ADJ (miss,male)
MOD_ATT:N-ADJ (miss,__SP__)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
COMP:V_PASS-N(from) (involve,miss)
SUBJ:V_PASS-N (involve,gland)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(after) (expression,treatment)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

name="reponse" value="A264">Analyse 264

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+-------------------------COMP:V_PASS-N(after)------------------------+      
      +-----COMP:N-N(from)----+                +----------------------------------SUBJ:V_PASS-N----------------------------------+            +-------COMP:N-N(of)-------+                             |      
      |          +-MOD_ATT:N-N+                +----------APPOS---------+                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+                             |      
      |          |     +MOD_AT+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,miss)
MOD_ATT:N-N (miss,male)
MOD_ATT:N-ADJ (miss,__SP__)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
SUBJ:V_PASS-N (involve,gland)
COMP:V_PASS-N(in) (involve,expression)
COMP:V_PASS-N(after) (involve,treatment)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

name="reponse" value="A265">Analyse 265

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+-------------------------COMP:V_PASS-N(after)------------------------+      
      +-----COMP:N-N(from)----+                +----------------------------------SUBJ:V_PASS-N----------------------------------+            +-------COMP:N-N(of)-------+                             |      
      |          +-MOD_ATT:N-N+                +----------APPOS---------+                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+                             |      
      |          |     +MOD_AT+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,miss)
MOD_ATT:N-N (miss,male)
MOD_ATT:N-ADJ (miss,__SP__)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
SUBJ:V_PASS-N (involve,gland)
COMP:V_PASS-N(in) (involve,expression)
COMP:V_PASS-N(after) (involve,treatment)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

name="reponse" value="A266">Analyse 266

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+-------------------------COMP:V_PASS-N(after)------------------------+      
      +-----COMP:N-N(from)----+                +----------------------------------SUBJ:V_PASS-N----------------------------------+            +-------COMP:N-N(of)-------+                             |      
      |          +-MOD_ATT:N-N+                +----------APPOS---------+                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+                             |      
      |          |     +MOD_AT+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,miss)
MOD_ATT:N-N (miss,male)
MOD_ATT:N-ADJ (miss,__SP__)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
SUBJ:V_PASS-N (involve,gland)
COMP:V_PASS-N(in) (involve,expression)
COMP:V_PASS-N(after) (involve,treatment)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

name="reponse" value="A267">Analyse 267

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+-------------------------COMP:V_PASS-N(after)------------------------+      
      +-----COMP:N-N(from)----+                +----------------------------------SUBJ:V_PASS-N----------------------------------+            +-------COMP:N-N(of)-------+                             |      
      |          +-MOD_ATT:N-N+                +----------APPOS---------+                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+                             |      
      |          |     +MOD_AT+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,miss)
MOD_ATT:N-N (miss,male)
MOD_ATT:N-ADJ (miss,__SP__)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
SUBJ:V_PASS-N (involve,gland)
COMP:V_PASS-N(in) (involve,expression)
COMP:V_PASS-N(after) (involve,treatment)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

name="reponse" value="A268">Analyse 268

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+                                                                            
      |                       +----------------------------------------COMP:V_PASS-N(from)---------------------------------------+-------------------------COMP:V_PASS-N(after)------------------------+      
      |                       |                +----------------------------------SUBJ:V_PASS-N----------------------------------+            +-------COMP:N-N(of)-------+                             |      
      |          +-MOD_ATT:N-N+                +----------APPOS---------+                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+                             |      
      |          |     +MOD_AT+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
MOD_ATT:N-N (miss,male)
MOD_ATT:N-ADJ (miss,__SP__)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
COMP:V_PASS-N(from) (involve,miss)
SUBJ:V_PASS-N (involve,gland)
COMP:V_PASS-N(in) (involve,expression)
COMP:V_PASS-N(after) (involve,treatment)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

name="reponse" value="A269">Analyse 269

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+                                                                            
      |                       +----------------------------------------COMP:V_PASS-N(from)---------------------------------------+-------------------------COMP:V_PASS-N(after)------------------------+      
      |                       |                +----------------------------------SUBJ:V_PASS-N----------------------------------+            +-------COMP:N-N(of)-------+                             |      
      |          +-MOD_ATT:N-N+                +----------APPOS---------+                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+                             |      
      |          |     +MOD_AT+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
MOD_ATT:N-N (miss,male)
MOD_ATT:N-ADJ (miss,__SP__)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
COMP:V_PASS-N(from) (involve,miss)
SUBJ:V_PASS-N (involve,gland)
COMP:V_PASS-N(in) (involve,expression)
COMP:V_PASS-N(after) (involve,treatment)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

name="reponse" value="A270">Analyse 270

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+                                                                            
      |                       +----------------------------------------COMP:V_PASS-N(from)---------------------------------------+-------------------------COMP:V_PASS-N(after)------------------------+      
      |                       |                +----------------------------------SUBJ:V_PASS-N----------------------------------+            +-------COMP:N-N(of)-------+                             |      
      |          +-MOD_ATT:N-N+                +----------APPOS---------+                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+                             |      
      |          |     +MOD_AT+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
MOD_ATT:N-N (miss,male)
MOD_ATT:N-ADJ (miss,__SP__)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
COMP:V_PASS-N(from) (involve,miss)
SUBJ:V_PASS-N (involve,gland)
COMP:V_PASS-N(in) (involve,expression)
COMP:V_PASS-N(after) (involve,treatment)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

name="reponse" value="A271">Analyse 271

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+                                                                            
      |                       +----------------------------------------COMP:V_PASS-N(from)---------------------------------------+-------------------------COMP:V_PASS-N(after)------------------------+      
      |                       |                +----------------------------------SUBJ:V_PASS-N----------------------------------+            +-------COMP:N-N(of)-------+                             |      
      |          +-MOD_ATT:N-N+                +----------APPOS---------+                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+                             |      
      |          |     +MOD_AT+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
MOD_ATT:N-N (miss,male)
MOD_ATT:N-ADJ (miss,__SP__)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
COMP:V_PASS-N(from) (involve,miss)
SUBJ:V_PASS-N (involve,gland)
COMP:V_PASS-N(in) (involve,expression)
COMP:V_PASS-N(after) (involve,treatment)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

name="reponse" value="A272">Analyse 272

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+                                                                            
      +-----COMP:N-N(from)----+                +----------------------------------SUBJ:V_PASS-N----------------------------------+            +-------COMP:N-N(of)-------+                                    
      |          +-MOD_ATT:N-N+                +----------APPOS---------+                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+-------COMP:N-N(after)-------+      
      |          |     +MOD_AT+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,miss)
MOD_ATT:N-N (miss,male)
MOD_ATT:N-ADJ (miss,__SP__)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
SUBJ:V_PASS-N (involve,gland)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(after) (mRNA,treatment)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

name="reponse" value="A273">Analyse 273

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+                                                                            
      +-----COMP:N-N(from)----+                +----------------------------------SUBJ:V_PASS-N----------------------------------+            +-------COMP:N-N(of)-------+                                    
      |          +-MOD_ATT:N-N+                +----------APPOS---------+                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+-------COMP:N-N(after)-------+      
      |          |     +MOD_AT+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,miss)
MOD_ATT:N-N (miss,male)
MOD_ATT:N-ADJ (miss,__SP__)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
SUBJ:V_PASS-N (involve,gland)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(after) (mRNA,treatment)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

name="reponse" value="A274">Analyse 274

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+                                                                            
      +-----COMP:N-N(from)----+                +----------------------------------SUBJ:V_PASS-N----------------------------------+            +-------COMP:N-N(of)-------+                                    
      |          +-MOD_ATT:N-N+                +----------APPOS---------+                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+-------COMP:N-N(after)-------+      
      |          |     +MOD_AT+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,miss)
MOD_ATT:N-N (miss,male)
MOD_ATT:N-ADJ (miss,__SP__)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
SUBJ:V_PASS-N (involve,gland)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(after) (mRNA,treatment)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

name="reponse" value="A275">Analyse 275

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+                                                                            
      +-----COMP:N-N(from)----+                +----------------------------------SUBJ:V_PASS-N----------------------------------+            +-------COMP:N-N(of)-------+                                    
      |          +-MOD_ATT:N-N+                +----------APPOS---------+                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+-------COMP:N-N(after)-------+      
      |          |     +MOD_AT+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,miss)
MOD_ATT:N-N (miss,male)
MOD_ATT:N-ADJ (miss,__SP__)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
SUBJ:V_PASS-N (involve,gland)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(after) (mRNA,treatment)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

name="reponse" value="A276">Analyse 276

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+            +---------------------COMP:N-N(after)--------------------+      
      +-----COMP:N-N(from)----+                +----------------------------------SUBJ:V_PASS-N----------------------------------+            +-------COMP:N-N(of)-------+                             |      
      |          +-MOD_ATT:N-N+                +----------APPOS---------+                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+                             |      
      |          |     +MOD_AT+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,miss)
MOD_ATT:N-N (miss,male)
MOD_ATT:N-ADJ (miss,__SP__)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
SUBJ:V_PASS-N (involve,gland)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(after) (expression,treatment)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

name="reponse" value="A277">Analyse 277

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+            +---------------------COMP:N-N(after)--------------------+      
      +-----COMP:N-N(from)----+                +----------------------------------SUBJ:V_PASS-N----------------------------------+            +-------COMP:N-N(of)-------+                             |      
      |          +-MOD_ATT:N-N+                +----------APPOS---------+                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+                             |      
      |          |     +MOD_AT+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,miss)
MOD_ATT:N-N (miss,male)
MOD_ATT:N-ADJ (miss,__SP__)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
SUBJ:V_PASS-N (involve,gland)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(after) (expression,treatment)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

name="reponse" value="A278">Analyse 278

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+                                                                            
      |                       +----------------------------------------COMP:V_PASS-N(from)---------------------------------------+                                                                            
      |                       |                +----------------------------------SUBJ:V_PASS-N----------------------------------+            +-------COMP:N-N(of)-------+                                    
      |          +-MOD_ATT:N-N+                +----------APPOS---------+                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+-------COMP:N-N(after)-------+      
      |          |     +MOD_AT+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
MOD_ATT:N-N (miss,male)
MOD_ATT:N-ADJ (miss,__SP__)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
COMP:V_PASS-N(from) (involve,miss)
SUBJ:V_PASS-N (involve,gland)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(after) (mRNA,treatment)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

name="reponse" value="A279">Analyse 279

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+                                                                            
      |                       +----------------------------------------COMP:V_PASS-N(from)---------------------------------------+                                                                            
      |                       |                +----------------------------------SUBJ:V_PASS-N----------------------------------+            +-------COMP:N-N(of)-------+                                    
      |          +-MOD_ATT:N-N+                +----------APPOS---------+                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+-------COMP:N-N(after)-------+      
      |          |     +MOD_AT+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
MOD_ATT:N-N (miss,male)
MOD_ATT:N-ADJ (miss,__SP__)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
COMP:V_PASS-N(from) (involve,miss)
SUBJ:V_PASS-N (involve,gland)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(after) (mRNA,treatment)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

name="reponse" value="A280">Analyse 280

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+            +---------------------COMP:N-N(after)--------------------+      
      +-----COMP:N-N(from)----+                +----------------------------------SUBJ:V_PASS-N----------------------------------+            +-------COMP:N-N(of)-------+                             |      
      |          +-MOD_ATT:N-N+                +----------APPOS---------+                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+                             |      
      |          |     +MOD_AT+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,miss)
MOD_ATT:N-N (miss,male)
MOD_ATT:N-ADJ (miss,__SP__)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
SUBJ:V_PASS-N (involve,gland)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(after) (expression,treatment)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

name="reponse" value="A281">Analyse 281

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+            +---------------------COMP:N-N(after)--------------------+      
      +-----COMP:N-N(from)----+                +----------------------------------SUBJ:V_PASS-N----------------------------------+            +-------COMP:N-N(of)-------+                             |      
      |          +-MOD_ATT:N-N+                +----------APPOS---------+                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+                             |      
      |          |     +MOD_AT+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,miss)
MOD_ATT:N-N (miss,male)
MOD_ATT:N-ADJ (miss,__SP__)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
SUBJ:V_PASS-N (involve,gland)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(after) (expression,treatment)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

name="reponse" value="A282">Analyse 282

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+                                                                            
      |                       +----------------------------------------COMP:V_PASS-N(from)---------------------------------------+                                                                            
      |                       |                +----------------------------------SUBJ:V_PASS-N----------------------------------+            +-------COMP:N-N(of)-------+                                    
      |          +-MOD_ATT:N-N+                +----------APPOS---------+                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+-------COMP:N-N(after)-------+      
      |          |     +MOD_AT+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
MOD_ATT:N-N (miss,male)
MOD_ATT:N-ADJ (miss,__SP__)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
COMP:V_PASS-N(from) (involve,miss)
SUBJ:V_PASS-N (involve,gland)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(after) (mRNA,treatment)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

name="reponse" value="A283">Analyse 283

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+                                                                            
      |                       +----------------------------------------COMP:V_PASS-N(from)---------------------------------------+                                                                            
      |                       |                +----------------------------------SUBJ:V_PASS-N----------------------------------+            +-------COMP:N-N(of)-------+                                    
      |          +-MOD_ATT:N-N+                +----------APPOS---------+                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+-------COMP:N-N(after)-------+      
      |          |     +MOD_AT+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
MOD_ATT:N-N (miss,male)
MOD_ATT:N-ADJ (miss,__SP__)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
COMP:V_PASS-N(from) (involve,miss)
SUBJ:V_PASS-N (involve,gland)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(after) (mRNA,treatment)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

name="reponse" value="A284">Analyse 284

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+                                                                            
      |                       +----------------------------------------COMP:V_PASS-N(from)---------------------------------------+            +---------------------COMP:N-N(after)--------------------+      
      |                       |                +----------------------------------SUBJ:V_PASS-N----------------------------------+            +-------COMP:N-N(of)-------+                             |      
      |          +-MOD_ATT:N-N+                +----------APPOS---------+                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+                             |      
      |          |     +MOD_AT+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
MOD_ATT:N-N (miss,male)
MOD_ATT:N-ADJ (miss,__SP__)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
COMP:V_PASS-N(from) (involve,miss)
SUBJ:V_PASS-N (involve,gland)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(after) (expression,treatment)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

name="reponse" value="A285">Analyse 285

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+                                                                            
      |                       +----------------------------------------COMP:V_PASS-N(from)---------------------------------------+            +---------------------COMP:N-N(after)--------------------+      
      |                       |                +----------------------------------SUBJ:V_PASS-N----------------------------------+            +-------COMP:N-N(of)-------+                             |      
      |          +-MOD_ATT:N-N+                +----------APPOS---------+                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+                             |      
      |          |     +MOD_AT+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
MOD_ATT:N-N (miss,male)
MOD_ATT:N-ADJ (miss,__SP__)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
COMP:V_PASS-N(from) (involve,miss)
SUBJ:V_PASS-N (involve,gland)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(after) (expression,treatment)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

name="reponse" value="A286">Analyse 286

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+                                                                            
      |                       +----------------------------------------COMP:V_PASS-N(from)---------------------------------------+            +---------------------COMP:N-N(after)--------------------+      
      |                       |                +----------------------------------SUBJ:V_PASS-N----------------------------------+            +-------COMP:N-N(of)-------+                             |      
      |          +-MOD_ATT:N-N+                +----------APPOS---------+                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+                             |      
      |          |     +MOD_AT+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
MOD_ATT:N-N (miss,male)
MOD_ATT:N-ADJ (miss,__SP__)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
COMP:V_PASS-N(from) (involve,miss)
SUBJ:V_PASS-N (involve,gland)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(after) (expression,treatment)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

name="reponse" value="A287">Analyse 287

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+                                                                            
      |                       +----------------------------------------COMP:V_PASS-N(from)---------------------------------------+            +---------------------COMP:N-N(after)--------------------+      
      |                       |                +----------------------------------SUBJ:V_PASS-N----------------------------------+            +-------COMP:N-N(of)-------+                             |      
      |          +-MOD_ATT:N-N+                +----------APPOS---------+                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+                             |      
      |          |     +MOD_AT+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
MOD_ATT:N-N (miss,male)
MOD_ATT:N-ADJ (miss,__SP__)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
COMP:V_PASS-N(from) (involve,miss)
SUBJ:V_PASS-N (involve,gland)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(after) (expression,treatment)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)